brijeshnair的个人主页 - 老虎社区

brijeshnair

brijeshnair

暂无个人介绍

IP属地：未知

7关注

1粉丝

0主题

0勋章

2021-12-21

Grt

Oracle to buy Cerner for $28 bln in healthcare sector push

2021-12-16

Like

Samsara jumped nearly 7%, with its IPO price at $23 per share

2021-12-11

[Happy]

Vaccine stocks dropped in morning trading

2021-11-22

Great

EU says decision on J&J COVID-19 vaccine booster dose 'within weeks'

2021-11-19

Good

Roblox reached an all-time high at 135.74 dollars as Morgan Stanley rose its price target by 70%

2021-11-01

Grt

Goldman Now Sees Fed Hiking Rates in July as Inflation Lingers

2021-10-15

Like

Generic drug maker Teligent files for bankruptcy protection, explores sale of the company

2021-10-13

Grt

Vistra Announces $2 Billion Share Repurchase Program

2021-10-12

Good info

BurgerFi To Acquire Anthony's Coal Fired Pizza & Wings For $161.3M

2021-10-10

Good info

Nikola inks hydrogen production deal with Canada's TC Energy

2021-10-04

Great

Top Wall Street analysts picks these 5 stocks for the fourth quarter

2021-10-03

Yes offcourse

抱歉，原内容已删除

2021-09-30

Good info

抱歉，原内容已删除

2021-09-30

Great

4 Stocks Expected to Increase Sales 25,750% to 2,970,000% in 5 Years

2021-09-29

Grt

Wall Street swoons on rising Treasury yields, growing inflation worries

2021-09-28

Nice

抱歉，原内容已删除

2021-09-28

Grt

Amazon Stock Falls. Morgan Stanley Cuts Its Price Target.

2021-09-28

Interesting

抱歉，原内容已删除

2021-09-28

Like

抱歉，原内容已删除

2021-09-28

Nice info

Merck in advanced talks to buy Acceleron Pharma - WSJ

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":4092798624667290,"uuid":"4092798624667290","gmtCreate":1629695560127,"gmtModify":1629771434427,"name":"brijeshnair","pinyin":"brijeshnair","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":7,"tweetSize":37,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.03.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.04.15","exceedPercentage":"60.76%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":693672096,"gmtCreate":1640019767125,"gmtModify":1640019767190,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Grt","listText":"Grt","text":"Grt","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693672096","repostId":"2192804351","repostType":4,"repost":{"id":"2192804351","pubTimestamp":1640013682,"share":"https://www.laohu8.com/m/news/2192804351?lang=&edition=full","pubTime":"2021-12-20 23:21","market":"us","language":"en","title":"Oracle to buy Cerner for $28 bln in healthcare sector push","url":"https://stock-news.laohu8.com/highlight/detail?id=2192804351","media":"Reuters","summary":"Dec 20 (Reuters) - Enterprise software maker Oracle Corp said on Monday it would buy electronic medi","content":"<p>Dec 20 (Reuters) - Enterprise software maker Oracle Corp said on Monday it would buy electronic medical records company Cerner Corp for $28.3 billion, in a bid to strengthen its presence in the healthcare sector.</p>\n<p>Cerner shareholders will receive $95 in cash for each share they hold, representing a premium of 5.8% to the company's closing price on Friday.</p>\n<p>The deal, which will be Oracle's biggest ever after its acquisition of PeopleSoft in 2004, will help the software maker bolster the services its provides to healthcare clients, including insurers.</p>\n<p>Cerner, the biggest seller of software used for electronic recording of healthcare data in the United States after Epic Systems Corp, will give Oracle access to data it can use to train and improve its artificial intelligence-based cloud services.</p>\n<p>Since the pandemic began, demand for cloud-based solutions in the healthcare sector has picked up pace, including telehealth services as well as automation of health records.</p>\n<p>The deal is expected to close in 2022, the company said. (Reporting by Chavi Mehta and Tiyashi Datta in Bengaluru; Editing by Krishna Chandra Eluri)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oracle to buy Cerner for $28 bln in healthcare sector push</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOracle to buy Cerner for $28 bln in healthcare sector push\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-20 23:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-oracle-buy-cerner-28-144822643.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dec 20 (Reuters) - Enterprise software maker Oracle Corp said on Monday it would buy electronic medical records company Cerner Corp for $28.3 billion, in a bid to strengthen its presence in the ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-oracle-buy-cerner-28-144822643.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CERN":"美国塞纳","ORCL":"甲骨文","BK4167":"医疗保健技术"},"source_url":"https://finance.yahoo.com/news/1-oracle-buy-cerner-28-144822643.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2192804351","content_text":"Dec 20 (Reuters) - Enterprise software maker Oracle Corp said on Monday it would buy electronic medical records company Cerner Corp for $28.3 billion, in a bid to strengthen its presence in the healthcare sector.\nCerner shareholders will receive $95 in cash for each share they hold, representing a premium of 5.8% to the company's closing price on Friday.\nThe deal, which will be Oracle's biggest ever after its acquisition of PeopleSoft in 2004, will help the software maker bolster the services its provides to healthcare clients, including insurers.\nCerner, the biggest seller of software used for electronic recording of healthcare data in the United States after Epic Systems Corp, will give Oracle access to data it can use to train and improve its artificial intelligence-based cloud services.\nSince the pandemic began, demand for cloud-based solutions in the healthcare sector has picked up pace, including telehealth services as well as automation of health records.\nThe deal is expected to close in 2022, the company said. (Reporting by Chavi Mehta and Tiyashi Datta in Bengaluru; Editing by Krishna Chandra Eluri)","news_type":1},"isVote":1,"tweetType":1,"viewCount":403,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607780455,"gmtCreate":1639592640979,"gmtModify":1639592641074,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607780455","repostId":"1124789927","repostType":4,"repost":{"id":"1124789927","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639589042,"share":"https://www.laohu8.com/m/news/1124789927?lang=&edition=full","pubTime":"2021-12-16 01:24","market":"us","language":"en","title":"Samsara jumped nearly 7%, with its IPO price at $23 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=1124789927","media":"Tiger Newspress","summary":"Samsara jumped nearly 7%, with its IPO price at $23 per share.Its initial public offering was priced","content":"<p>Samsara&nbsp;jumped&nbsp;nearly&nbsp;7%,&nbsp;with&nbsp;its&nbsp;IPO&nbsp;price&nbsp;at&nbsp;$23 per share.<img src=\"https://static.tigerbbs.com/3f42428454fe98bb007b0939f16efbe7\" tg-width=\"765\" tg-height=\"566\" width=\"100%\" height=\"auto\">Its initial public offering was priced at $23 a share, the high end of its expected range.</p>\n<p>Founded in 2015 by CEO Sanjit Biswas and&nbsp;John Bicket, chief technology officer,Samsara provides a connected operations cloud&nbsp;and sensors that are used by companies to manage their vehicle fleets and industrial operations.</p>\n<p>Samsara’s technology collects data including video footage, people and motion detection, GPS location, and energy consumption. Companies can use this information to improve safety, lower insurance costs and reduce the need for manual oversight and judgment, the prospectus said.</p>\n<p>It has more than 13,000 core customers, which it defines as entities with annual recurring revenue of greater than $5,000, including small businesses, state and local governments, and large, global enterprises.</p>\n<p>Samsara reported losses of $102.3 million for the nine months ended Oct. 30, compared with losses of $174 million in the same period a year earlier. Revenue rose 74% to $302.6 million during the period.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Samsara jumped nearly 7%, with its IPO price at $23 per share</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSamsara jumped nearly 7%, with its IPO price at $23 per share\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-16 01:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Samsara&nbsp;jumped&nbsp;nearly&nbsp;7%,&nbsp;with&nbsp;its&nbsp;IPO&nbsp;price&nbsp;at&nbsp;$23 per share.<img src=\"https://static.tigerbbs.com/3f42428454fe98bb007b0939f16efbe7\" tg-width=\"765\" tg-height=\"566\" width=\"100%\" height=\"auto\">Its initial public offering was priced at $23 a share, the high end of its expected range.</p>\n<p>Founded in 2015 by CEO Sanjit Biswas and&nbsp;John Bicket, chief technology officer,Samsara provides a connected operations cloud&nbsp;and sensors that are used by companies to manage their vehicle fleets and industrial operations.</p>\n<p>Samsara’s technology collects data including video footage, people and motion detection, GPS location, and energy consumption. Companies can use this information to improve safety, lower insurance costs and reduce the need for manual oversight and judgment, the prospectus said.</p>\n<p>It has more than 13,000 core customers, which it defines as entities with annual recurring revenue of greater than $5,000, including small businesses, state and local governments, and large, global enterprises.</p>\n<p>Samsara reported losses of $102.3 million for the nine months ended Oct. 30, compared with losses of $174 million in the same period a year earlier. Revenue rose 74% to $302.6 million during the period.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"IOT":"Samsara, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1124789927","content_text":"Samsara jumped nearly 7%, with its IPO price at $23 per share.Its initial public offering was priced at $23 a share, the high end of its expected range.\nFounded in 2015 by CEO Sanjit Biswas and John Bicket, chief technology officer,Samsara provides a connected operations cloud and sensors that are used by companies to manage their vehicle fleets and industrial operations.\nSamsara’s technology collects data including video footage, people and motion detection, GPS location, and energy consumption. Companies can use this information to improve safety, lower insurance costs and reduce the need for manual oversight and judgment, the prospectus said.\nIt has more than 13,000 core customers, which it defines as entities with annual recurring revenue of greater than $5,000, including small businesses, state and local governments, and large, global enterprises.\nSamsara reported losses of $102.3 million for the nine months ended Oct. 30, compared with losses of $174 million in the same period a year earlier. Revenue rose 74% to $302.6 million during the period.","news_type":1},"isVote":1,"tweetType":1,"viewCount":850,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605685662,"gmtCreate":1639152437752,"gmtModify":1639152437813,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"[Happy]&nbsp;","listText":"[Happy]&nbsp;","text":"[Happy]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605685662","repostId":"1148141788","repostType":4,"repost":{"id":"1148141788","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639147224,"share":"https://www.laohu8.com/m/news/1148141788?lang=&edition=full","pubTime":"2021-12-10 22:40","market":"us","language":"en","title":"Vaccine stocks dropped in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1148141788","media":"Tiger Newspress","summary":"Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.","content":"<p>Vaccine stocks dropped in morning trading.Moderna,BioNTech&nbsp;and&nbsp;Novavax&nbsp;fell&nbsp;between 2% and 11%.</p>\n<p><img src=\"https://static.tigerbbs.com/d3f84cfc9f83b59cf14210d41d97111a\" tg-width=\"415\" tg-height=\"302\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks dropped in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks dropped in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-10 22:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vaccine stocks dropped in morning trading.Moderna,BioNTech&nbsp;and&nbsp;Novavax&nbsp;fell&nbsp;between 2% and 11%.</p>\n<p><img src=\"https://static.tigerbbs.com/d3f84cfc9f83b59cf14210d41d97111a\" tg-width=\"415\" tg-height=\"302\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","BNTX":"BioNTech SE","MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1148141788","content_text":"Vaccine stocks dropped in morning trading.Moderna,BioNTech and Novavax fell between 2% and 11%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":411,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875981671,"gmtCreate":1637594521622,"gmtModify":1637594521622,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875981671","repostId":"2185874833","repostType":2,"repost":{"id":"2185874833","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1637588025,"share":"https://www.laohu8.com/m/news/2185874833?lang=&edition=full","pubTime":"2021-11-22 21:33","market":"us","language":"en","title":"EU says decision on J&J COVID-19 vaccine booster dose 'within weeks'","url":"https://stock-news.laohu8.com/highlight/detail?id=2185874833","media":"Reuters","summary":"Nov 22 (Reuters) - The European Union's drug regulator said on Monday it was evaluating data on boos","content":"<p>Nov 22 (Reuters) - The European Union's drug regulator said on Monday it was evaluating data on booster doses of the COVID-19 vaccine by Johnson &amp; Johnson&nbsp;and a decision could come \"within weeks\" under a speedy review.</p>\n<p>The application is for use of a booster dose of the vaccine, COVID-19 Vaccine Janssen, to be given at least two months after the first dose to people aged 18 years and older, the European Medicines Agency (EMA) said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EU says decision on J&J COVID-19 vaccine booster dose 'within weeks'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEU says decision on J&J COVID-19 vaccine booster dose 'within weeks'\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-11-22 21:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nov 22 (Reuters) - The European Union's drug regulator said on Monday it was evaluating data on booster doses of the COVID-19 vaccine by Johnson &amp; Johnson&nbsp;and a decision could come \"within weeks\" under a speedy review.</p>\n<p>The application is for use of a booster dose of the vaccine, COVID-19 Vaccine Janssen, to be given at least two months after the first dose to people aged 18 years and older, the European Medicines Agency (EMA) said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2185874833","content_text":"Nov 22 (Reuters) - The European Union's drug regulator said on Monday it was evaluating data on booster doses of the COVID-19 vaccine by Johnson & Johnson and a decision could come \"within weeks\" under a speedy review.\nThe application is for use of a booster dose of the vaccine, COVID-19 Vaccine Janssen, to be given at least two months after the first dose to people aged 18 years and older, the European Medicines Agency (EMA) said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":332,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876320323,"gmtCreate":1637274526267,"gmtModify":1637274526267,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876320323","repostId":"1130402483","repostType":4,"repost":{"id":"1130402483","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637246715,"share":"https://www.laohu8.com/m/news/1130402483?lang=&edition=full","pubTime":"2021-11-18 22:45","market":"us","language":"en","title":"Roblox reached an all-time high at 135.74 dollars as Morgan Stanley rose its price target by 70%","url":"https://stock-news.laohu8.com/highlight/detail?id=1130402483","media":"Tiger Newspress","summary":"Roblox reached an all-time high at 135.74 dollars as Morgan Stanley rose its price target by 70%.Rob","content":"<p>Roblox reached an all-time high at 135.74 dollars&nbsp;as Morgan Stanley rose its price target by 70%.<img src=\"https://static.tigerbbs.com/ea67fe79dc5cf395ce86763243316f95\" tg-width=\"778\" tg-height=\"565\" referrerpolicy=\"no-referrer\">Roblox announced on Wednesday (17th) that it will invest 10 million US dollars to develop three educational games for junior high school, high school and college students, and implant educational video games into school education.</p>\n<p>Morgan Stanley analyst Brian Nowak maintained Roblox's \"overweight\" rating and raised the target price from $88 to $150. Analysts said that Roblox is optimistic about its leading position in the early stage of meta-universe and higher long-term profitability because it is investing in improving user experience, developing tools and improving brand implantation capabilities. Analysts added that considering Roblox's existing in-app purchase revenue source, advertising revenue outside the stock's current premium was considered appropriate.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roblox reached an all-time high at 135.74 dollars as Morgan Stanley rose its price target by 70%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoblox reached an all-time high at 135.74 dollars as Morgan Stanley rose its price target by 70%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-18 22:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Roblox reached an all-time high at 135.74 dollars&nbsp;as Morgan Stanley rose its price target by 70%.<img src=\"https://static.tigerbbs.com/ea67fe79dc5cf395ce86763243316f95\" tg-width=\"778\" tg-height=\"565\" referrerpolicy=\"no-referrer\">Roblox announced on Wednesday (17th) that it will invest 10 million US dollars to develop three educational games for junior high school, high school and college students, and implant educational video games into school education.</p>\n<p>Morgan Stanley analyst Brian Nowak maintained Roblox's \"overweight\" rating and raised the target price from $88 to $150. Analysts said that Roblox is optimistic about its leading position in the early stage of meta-universe and higher long-term profitability because it is investing in improving user experience, developing tools and improving brand implantation capabilities. Analysts added that considering Roblox's existing in-app purchase revenue source, advertising revenue outside the stock's current premium was considered appropriate.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RBLX":"Roblox Corporation"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1130402483","content_text":"Roblox reached an all-time high at 135.74 dollars as Morgan Stanley rose its price target by 70%.Roblox announced on Wednesday (17th) that it will invest 10 million US dollars to develop three educational games for junior high school, high school and college students, and implant educational video games into school education.\nMorgan Stanley analyst Brian Nowak maintained Roblox's \"overweight\" rating and raised the target price from $88 to $150. Analysts said that Roblox is optimistic about its leading position in the early stage of meta-universe and higher long-term profitability because it is investing in improving user experience, developing tools and improving brand implantation capabilities. Analysts added that considering Roblox's existing in-app purchase revenue source, advertising revenue outside the stock's current premium was considered appropriate.","news_type":1},"isVote":1,"tweetType":1,"viewCount":587,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849149290,"gmtCreate":1635737599912,"gmtModify":1635737599968,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Grt","listText":"Grt","text":"Grt","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/849149290","repostId":"1159859530","repostType":4,"repost":{"id":"1159859530","pubTimestamp":1635726340,"share":"https://www.laohu8.com/m/news/1159859530?lang=&edition=full","pubTime":"2021-11-01 08:25","market":"us","language":"en","title":"Goldman Now Sees Fed Hiking Rates in July as Inflation Lingers","url":"https://stock-news.laohu8.com/highlight/detail?id=1159859530","media":"Bloomberg","summary":"(Bloomberg) -- Goldman Sachs Group Inc. economists said they now expect inflation will force the Fed","content":"<p>(Bloomberg) -- Goldman Sachs Group Inc. economists said they now expect inflation will force the Federal Reserve to hike interest rates next July, a year earlier than previously expected.</p>\n<p>In a report to clients late Friday, economists led by Jan Hatzius said the Fed will raise its benchmark from a range of zero to 0.25% soon after it stops tapering its massive asset-purchase program. A second increase will follow in November 2022 and the central bank will then raise rates two times a year after that, they said.</p>\n<p>Fed Chairman Jerome Powell and colleagues are predicted to announce next week that they will start slowing their buying of assets in November or December at a pace of around $15 billion a month. While policy makers have previously been divided over whether they expect to start raising rates in 2022 or 2023, investors have stepped up bets in recent weeks that inflation will force their hand next year.</p>\n<p>The Goldman economists said the main reason for their new forecast was they now expect inflation to prove more stubborn than they previously thought. They now expect consumer price inflation outside of food and energy costs to still be above 4% when the taper ends.</p>\n<p>“We think this will make a seamless move from tapering to rate hikes the path of least resistance,” they said in the report.</p>\n<p>The Fed has goals for both inflation and employment. While the Fed has said it wants maximum employment before increasing rates, Hatzius and his colleagues said with inflation far above target and job availability high, officials will likely conclude most of any remaining labor force weakness is structural or voluntary.</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Now Sees Fed Hiking Rates in July as Inflation Lingers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Now Sees Fed Hiking Rates in July as Inflation Lingers\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-01 08:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/goldman-now-sees-fed-hiking-061946072.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Goldman Sachs Group Inc. economists said they now expect inflation will force the Federal Reserve to hike interest rates next July, a year earlier than previously expected.\nIn a report ...</p>\n\n<a href=\"https://finance.yahoo.com/news/goldman-now-sees-fed-hiking-061946072.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯"},"source_url":"https://finance.yahoo.com/news/goldman-now-sees-fed-hiking-061946072.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159859530","content_text":"(Bloomberg) -- Goldman Sachs Group Inc. economists said they now expect inflation will force the Federal Reserve to hike interest rates next July, a year earlier than previously expected.\nIn a report to clients late Friday, economists led by Jan Hatzius said the Fed will raise its benchmark from a range of zero to 0.25% soon after it stops tapering its massive asset-purchase program. A second increase will follow in November 2022 and the central bank will then raise rates two times a year after that, they said.\nFed Chairman Jerome Powell and colleagues are predicted to announce next week that they will start slowing their buying of assets in November or December at a pace of around $15 billion a month. While policy makers have previously been divided over whether they expect to start raising rates in 2022 or 2023, investors have stepped up bets in recent weeks that inflation will force their hand next year.\nThe Goldman economists said the main reason for their new forecast was they now expect inflation to prove more stubborn than they previously thought. They now expect consumer price inflation outside of food and energy costs to still be above 4% when the taper ends.\n“We think this will make a seamless move from tapering to rate hikes the path of least resistance,” they said in the report.\nThe Fed has goals for both inflation and employment. While the Fed has said it wants maximum employment before increasing rates, Hatzius and his colleagues said with inflation far above target and job availability high, officials will likely conclude most of any remaining labor force weakness is structural or voluntary.","news_type":1},"isVote":1,"tweetType":1,"viewCount":699,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":824043682,"gmtCreate":1634264655689,"gmtModify":1634274404389,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/824043682","repostId":"1182032876","repostType":4,"repost":{"id":"1182032876","pubTimestamp":1634263136,"share":"https://www.laohu8.com/m/news/1182032876?lang=&edition=full","pubTime":"2021-10-15 09:58","market":"us","language":"en","title":"Generic drug maker Teligent files for bankruptcy protection, explores sale of the company","url":"https://stock-news.laohu8.com/highlight/detail?id=1182032876","media":"THE BUSINESS JOURNALS","summary":"South Jersey specialty generic pharmaceutical firm Teligent Inc. filed for voluntarily bankruptcy pr","content":"<p>South Jersey specialty generic pharmaceutical firm Teligent Inc. filed for voluntarily bankruptcy protection on Thursday as it pursues the sale of the company or its core assets.</p>\n<p>Teligent Inc. of Buena in Atlantic County also said it is arranging for $12 million debtor-in-possession financing from its senior secured lenders.</p>\n<p>The company also announced that CEO&nbsp;Tim SawyerandPhilip Yachmetz, Teligent's chief legal officer and executive vice president, resigned effective Oct. 8.</p>\n<p>Shares of the company are down 47% in pre-market trading Thursday to 18 cents.</p>\n<p>Teligent (NASDAQ: TLGT) filed for Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. The filing does not yet list specific assets and liabilities. It did note AmerisourceBergen (NYSE: ABC) is owed $8.3 million, making the Conshohocken-based wholesale pharmaceutical distributor Teligent's largest unsecured creditor.</p>\n<p>Teligent began marketing itself ahead of the Chapter 11 filing to determine the level of interest in the company and is in ongoing discussions with several interested parties, the company said. Teligent expects to finalize a sale of the entire business, or its core assets, by early 2022.</p>\n<p>\"The entire Teligent team has worked diligently over the past year to address market trends, our debt structure, and operational hurdles that have challenged our business,\" saidJohn Celentano, board chairman of Teligen, in a statement. \"While this is not the outcome we envisioned, we are confident that Teligent's business includes a strong portfolio of specialty generic prescription assets and believe a sale is the best opportunity to maximize value.\"</p>\n<p>Last year, Teligent generated revenue of $45.3 million and a net loss of $122 million. In 2019, it had sales of nearly $65.9 million and a loss of $25.1 million.</p>\n<p>Teligent has spent the past two years engaged in remediation efforts for its South Jersey manufacturing plant after the Food and Drug Administration cited deficiencies at the plant in a warning letter issued to the company in November 2019. Teligent halted its production of certain undisclosed products while it continues to work to address the FDA's concerns.</p>\n<p>The company's use of its newly constructed sterile injectable manufacturing plant has also been delayed because of the uncertainty regarding the timing the&nbsp;FDA's inspection of the site.</p>\n<p>Last month, Teligent issued a voluntary recall for a Lidocaine product because of a potency issue. The company has not received any reports of adverse events related to this recall.</p>\n<p>In connection with the bankruptcy filing, Teligent appointed&nbsp;Vladimir Kasparov, managing director at Portage Point Partners, as chief restructuring officer.</p>\n<p>Founded in 1977, Teligent markets more than three dozen generic topical pharmaceutical products formulated as ointments, creams, lotions and gels. The company has over 140 employees, including 114 in Canada.</p>\n<p>The company's Canadian affiliate, Teligent Canada, will be pursuing an out-of-court sale process.</p>","source":"lsy1633760424806","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Generic drug maker Teligent files for bankruptcy protection, explores sale of the company</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGeneric drug maker Teligent files for bankruptcy protection, explores sale of the company\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-15 09:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bizjournals.com/philadelphia/news/2021/10/14/teligent-buena-south-jersey-chapter-11-bankruptcy.html?ana=yahoo><strong>THE BUSINESS JOURNALS</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>South Jersey specialty generic pharmaceutical firm Teligent Inc. filed for voluntarily bankruptcy protection on Thursday as it pursues the sale of the company or its core assets.\nTeligent Inc. of ...</p>\n\n<a href=\"https://www.bizjournals.com/philadelphia/news/2021/10/14/teligent-buena-south-jersey-chapter-11-bankruptcy.html?ana=yahoo\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.bizjournals.com/philadelphia/news/2021/10/14/teligent-buena-south-jersey-chapter-11-bankruptcy.html?ana=yahoo","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1182032876","content_text":"South Jersey specialty generic pharmaceutical firm Teligent Inc. filed for voluntarily bankruptcy protection on Thursday as it pursues the sale of the company or its core assets.\nTeligent Inc. of Buena in Atlantic County also said it is arranging for $12 million debtor-in-possession financing from its senior secured lenders.\nThe company also announced that CEO Tim SawyerandPhilip Yachmetz, Teligent's chief legal officer and executive vice president, resigned effective Oct. 8.\nShares of the company are down 47% in pre-market trading Thursday to 18 cents.\nTeligent (NASDAQ: TLGT) filed for Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. The filing does not yet list specific assets and liabilities. It did note AmerisourceBergen (NYSE: ABC) is owed $8.3 million, making the Conshohocken-based wholesale pharmaceutical distributor Teligent's largest unsecured creditor.\nTeligent began marketing itself ahead of the Chapter 11 filing to determine the level of interest in the company and is in ongoing discussions with several interested parties, the company said. Teligent expects to finalize a sale of the entire business, or its core assets, by early 2022.\n\"The entire Teligent team has worked diligently over the past year to address market trends, our debt structure, and operational hurdles that have challenged our business,\" saidJohn Celentano, board chairman of Teligen, in a statement. \"While this is not the outcome we envisioned, we are confident that Teligent's business includes a strong portfolio of specialty generic prescription assets and believe a sale is the best opportunity to maximize value.\"\nLast year, Teligent generated revenue of $45.3 million and a net loss of $122 million. In 2019, it had sales of nearly $65.9 million and a loss of $25.1 million.\nTeligent has spent the past two years engaged in remediation efforts for its South Jersey manufacturing plant after the Food and Drug Administration cited deficiencies at the plant in a warning letter issued to the company in November 2019. Teligent halted its production of certain undisclosed products while it continues to work to address the FDA's concerns.\nThe company's use of its newly constructed sterile injectable manufacturing plant has also been delayed because of the uncertainty regarding the timing the FDA's inspection of the site.\nLast month, Teligent issued a voluntary recall for a Lidocaine product because of a potency issue. The company has not received any reports of adverse events related to this recall.\nIn connection with the bankruptcy filing, Teligent appointed Vladimir Kasparov, managing director at Portage Point Partners, as chief restructuring officer.\nFounded in 1977, Teligent markets more than three dozen generic topical pharmaceutical products formulated as ointments, creams, lotions and gels. The company has over 140 employees, including 114 in Canada.\nThe company's Canadian affiliate, Teligent Canada, will be pursuing an out-of-court sale process.","news_type":1},"isVote":1,"tweetType":1,"viewCount":590,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":822910326,"gmtCreate":1634084132917,"gmtModify":1634084133026,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Grt","listText":"Grt","text":"Grt","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/822910326","repostId":"2175137885","repostType":4,"repost":{"id":"2175137885","pubTimestamp":1634082300,"share":"https://www.laohu8.com/m/news/2175137885?lang=&edition=full","pubTime":"2021-10-13 07:45","market":"us","language":"en","title":"Vistra Announces $2 Billion Share Repurchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2175137885","media":"PR Newswire","summary":"Company Prices Private Offering of $1 Billion of Series A Preferred Stock with Net Proceeds to be Us","content":"<div>\n<p>Company Prices Private Offering of $1 Billion of Series A Preferred Stock with Net Proceeds to be Used to Repurchase Common Stock\nIRVING, Texas, Oct. 12, 2021 /PRNewswire/ -- Vistra Corp. (NYSE: VST) ...</p>\n\n<a href=\"https://finance.yahoo.com/news/vistra-announces-2-billion-share-204500612.html\">Web Link</a>\n\n</div>\n","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vistra Announces $2 Billion Share Repurchase Program</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVistra Announces $2 Billion Share Repurchase Program\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-13 07:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/vistra-announces-2-billion-share-204500612.html><strong>PR Newswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Company Prices Private Offering of $1 Billion of Series A Preferred Stock with Net Proceeds to be Used to Repurchase Common Stock\nIRVING, Texas, Oct. 12, 2021 /PRNewswire/ -- Vistra Corp. (NYSE: VST) ...</p>\n\n<a href=\"https://finance.yahoo.com/news/vistra-announces-2-billion-share-204500612.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VST":"Vistra Energy Corp."},"source_url":"https://finance.yahoo.com/news/vistra-announces-2-billion-share-204500612.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2175137885","content_text":"Company Prices Private Offering of $1 Billion of Series A Preferred Stock with Net Proceeds to be Used to Repurchase Common Stock\nIRVING, Texas, Oct. 12, 2021 /PRNewswire/ -- Vistra Corp. (NYSE: VST) (the \"Company\" or \"Vistra\") today announced a new $2 billion share repurchase program and the pricing of a private offering (the \"Offering\") of 1,000,000 shares of its 8% Series A Fixed-Rate Reset Cumulative Redeemable Perpetual Preferred Stock (the \"Preferred Stock\") to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the \"Securities Act\"), and to certain non-U.S. persons in accordance with Regulation S under the Securities Act, at an offering price of $1,000 per share. The Company will receive gross proceeds of $1 billion from the sale of the Preferred Stock before deducting the initial purchaser discount and other estimated offering expenses. The Offering is expected to close on Oct. 15, 2021, subject to customary closing conditions.\n\nAs an initial step in its broader capital allocation plan, the Company intends to use the net proceeds from the Offering to repurchase its common stock beginning as early as early November 2021. Vistra's Board of Directors (\"Board\") has adopted a new $2 billion share repurchase program, effective immediately (superseding its prior $1.5 billion repurchase program, which had approximately $1.325 billion of remaining authorization). The Company intends to execute the share repurchases under this new program from November 2021 to the end of December 2022. The timing and amount of share repurchases will be announced publicly each quarter in arrears, consistent with Vistra's historical practice.\nThe share repurchase program announced today is aligned with the Company's previously announced strategic and capital allocation review seeking to enhance shareholder returns. Vistra's strategic review has identified and prioritized four key strategic imperatives, including:\n\nDriving long-term, sustainable value through Vistra's integrated business model. Vistra management believes the pairing of its low-cost, efficient, and diversified generation fleet, including its burgeoning zero-carbon business, with its customer-centric retail platform and best-in-class commercial capabilities is the optimal way to create value for its shareholders in the dynamic, competitive markets where the Company operates.\nReturning significant capital to shareholders. Vistra expects it will use a significant portion of its free cash flow to repurchase its shares and expects it will continue to pay a meaningful dividend on its common stock. Today's announcement advances one of Vistra's core capital allocation priorities by using lower-cost capital to accelerate the Company's ability to repurchase its severely discounted shares. The repurchases will reduce the total number of shares outstanding, which over time should accrue value to Vistra's remaining shareholders.\n\nRepurchasing Vistra's undervalued shares of common stock. At Vistra's current undervalued stock price, and assuming on average at least $3+ billion of Adjusted EBITDA from Ongoing Operations and 60%+ free cash flow conversion on an annual basis, the Company estimates it could repurchase at least $5 billion of common stock by year-end 2025, approximating 60% of its current market capitalization and by the end of the decade return its entire current market capitalization to shareholders without negatively impacting the earnings power of the business.  The Company is committed to allocating a significant amount of its capital to share repurchases until the public equity markets reflect a valuation for Vistra that is consistent with management and the Board's view of fair value.\nPrioritizing a meaningful dividend on its common stock. We anticipate the capital allocated to common dividends will grow on a per-share basis (subject to Board authorization), though with fewer shares outstanding, we expect the gross amount to decrease, freeing up capital for other uses.\n\nMaintaining a strong balance sheet. Vistra expects it will continue to pay down debt over time in order to maintain a strong balance sheet, allowing the Company to manage commodity and climate change risk, and positioning it to prudently pursue opportunistic growth. By year-end 2022, the Company expects to reduce a meaningful portion of the $2 billion in increased debt resulting from the impacts of Winter Storm Uri.\nAccelerating our zero-carbon growth pipeline with cost-efficient capital. Vistra intends to participate in the electric industry transition utilizing its strong capabilities, attractive and significant pipeline of zero-carbon projects, and access to low-cost capital.\n\nVistra has nearly 4,000 megawatts of zero-carbon assets online or under development with more than 3,000 MW of zero-carbon assets in its development pipeline, including approximately 450 MW of solar and storage in downstate Illinois, supported by the recently enacted Coal to Solar and Energy Storage initiative. The Company intends to accelerate the development of its battery energy storage and renewable projects by accessing the significant availability of third-party, cost-effective capital seeking green investments – both debt and equity. The event at the 300-MW / 1200-MWh Phase I building of Vistra's Moss Landing Energy Storage Facility slightly delayed the Company's execution of this financing strategy, though the Company expects it will have achieved meaningful progress on the capital raise by mid-December.\nThis zero-carbon pipeline complements Vistra's recently accelerated target reductions in greenhouse gas emissions. Vistra has a goal to achieve a 60% reduction in CO2 equivalent emissions by 2030, as compared to a 2010 baseline, and a long-term objective to achieve net-zero carbon emissions by 2050.1 Vistra is already 75% of the way toward achieving its 2030 goal and recently joined SBTi's Business Ambition for 1.5°C, committing to align emissions reduction targets with the Paris Agreement to keep warming to 1.5°C and reaching science-based net-zero emissions by 2050.\n\n\nVistra's announcement today of this share repurchase program is the first step in launching the details of the Company's strategic review. Additional details outlining Vistra's strategic imperatives are forthcoming.\n(1) Assuming necessary advancements in technology and supportive market constructs and public policy.\n\"Today, Vistra took an important first step in executing on the output of its strategic review by taking advantage of the unprecedented and unsustainable differences in the cost of capital implied in its equity value as compared to other forms of capital, such as debt and preferred stock,\" said Curt Morgan, Vistra's chief executive officer. \"This announcement underscores our confidence in the business and commitment to enhancing shareholder value while maintaining our strong balance sheet. The strategic imperatives announced today are a result of a months-long strategic review by the Company, including our Board – positioning Vistra to deliver strong, consistent long-term earnings into the future, while investing in our attractive retail and zero-carbon businesses and returning a significant amount of our free cash flow to shareholders on an annual basis. We believe in the value of this company and will continue to take actions to rectify the significant undervaluation of our stock.\"\nDetails on the Preferred Stock\nThe annual dividend rate on each share of Preferred Stock is 8.0% from the original issuance date to, but excluding, Oct. 15, 2026 (the \"First Reset Date\"). On and after the First Reset Date, the dividend rate on each share of Preferred Stock shall equal the five-year U.S. Treasury rate as of the most recent reset dividend determination date (subject to a floor of 1.07%), plus a spread of 6.93% per annum. The Preferred Stock has a liquidation preference of $1,000 per share, plus accumulated but unpaid dividends. Cumulative cash dividends on the Preferred Stock are payable semiannually, in arrears, on each April 15 and Oct. 15, commencing on April 15, 2022, when, as and if declared by the Company's Board.\nThe Preferred Stock is not convertible into or exchangeable for any other securities of the Company and will have limited voting rights. The Preferred Stock may be redeemed at the option of the Company in certain circumstances.\nThe Preferred Stock will not be registered under the Securities Act or any state securities laws and may not be offered or sold in the U.S. absent registration or an applicable exemption from such registration requirements.\nThis press release shall not constitute an offer to sell or a solicitation of an offer to buy the Preferred Stock, nor shall there be any sale of the Preferred Stock in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.\nAbout Vistra\nVistra (NYSE: VST) is a leading, Fortune 275 integrated retail electricity and power generation company based in Irving, Texas, providing essential resources for customers, commerce, and communities. Vistra combines an innovative, customer-centric approach to retail with safe, reliable, diverse, and efficient power generation. The company brings its products and services to market in 20 states and the District of Columbia, including six of the seven competitive wholesale markets in the U.S. and markets in Canada and Japan, as well. Serving nearly 4.3 million residential, commercial, and industrial retail customers with electricity and natural gas, Vistra is one of the largest competitive residential electricity providers in the country and offers over 50 renewable energy plans. The company is also the largest competitive power generator in the U.S., with a capacity of approximately 39,000 megawatts powered by a diverse portfolio, including natural gas, nuclear, solar, and battery energy storage facilities. In addition, Vistra is a large purchaser of wind power. The company owns and operates a 400-MW/1,600-MWh battery energy storage system in Moss Landing, California, the largest of its kind in the world. Vistra is guided by four core principles: we do business the right way, we work as a team, we compete to win, and we care about our stakeholders, including our customers, our communities where we work and live, our employees, and our investors.","news_type":1},"isVote":1,"tweetType":1,"viewCount":663,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":826694096,"gmtCreate":1634010123981,"gmtModify":1634010123981,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good info","listText":"Good info","text":"Good info","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/826694096","repostId":"2174186083","repostType":4,"repost":{"id":"2174186083","pubTimestamp":1634007200,"share":"https://www.laohu8.com/m/news/2174186083?lang=&edition=full","pubTime":"2021-10-12 10:53","market":"us","language":"en","title":"BurgerFi To Acquire Anthony's Coal Fired Pizza & Wings For $161.3M","url":"https://stock-news.laohu8.com/highlight/detail?id=2174186083","media":"Benzinga","summary":"BurgerFi International Inc (NASDAQ: BFI) has agreed to acquire Anthony's Coal Fired Pizza & Wings fr","content":"<ul>\n <li><b>BurgerFi International Inc&nbsp;</b>(NASDAQ: BFI)&nbsp;has agreed to acquire Anthony's Coal Fired Pizza &amp; Wings&nbsp;from private equity firm&nbsp;<i>L&nbsp;</i>Catterton for about $161.3 million.</li>\n <li>Fort Lauderdale, Florida-based Anthony's, founded in 2002, is an operator of casual dining pizza restaurants.</li>\n <li>The deal price comprises $33.6 million in common stock, $53.0 million in new junior non-convertible preferred equity, and the assumption of estimated $74.7 million debt, all subject to closing adjustments.</li>\n <li>At the closing of the transaction,&nbsp;<i>L&nbsp;</i>Catterton will become <a href=\"https://laohu8.com/S/AONE.U\">one</a> of BurgerFi's largest shareholders. Andrew Taub, a Managing Partner at&nbsp;<i>L&nbsp;</i>Catterton, will be joining BurgerFi's board following the completion of the transaction expected to occur in the fourth quarter of 2021.</li>\n <li>BurgerFi expects the transaction to be accretive to EPS to common shareholders and EBITDA in 2022.</li>\n <li>Ophir Sternberg will lead both the BurgerFi and Anthony's brands in his continuing role of Executive Chairman of BurgerFi, and Mike Rabinovitch will continue as BurgerFi CFO.</li>\n <li>At the closing of the transaction, Ian Baines will become the CEO of BurgerFi, while Julio Ramirez will remain CEO and President of the BurgerFi brand, and Patrick Renna will become President of Anthony's brand.</li>\n <li>BurgerFi&nbsp;held .75 million in cash and equivalents&nbsp;as of June 30, 2021.</li>\n <li><b>Price Action:</b>&nbsp;BFI shares closed higher by 5.77% at $8.43 on Monday.</li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BurgerFi To Acquire Anthony's Coal Fired Pizza & Wings For $161.3M</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBurgerFi To Acquire Anthony's Coal Fired Pizza & Wings For $161.3M\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-12 10:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/burgerfi-acquire-anthonys-coal-fired-202220177.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BurgerFi International Inc (NASDAQ: BFI) has agreed to acquire Anthony's Coal Fired Pizza & Wings from private equity firm L Catterton for about $161.3 million.\nFort Lauderdale, Florida-based Anthony'...</p>\n\n<a href=\"https://finance.yahoo.com/news/burgerfi-acquire-anthonys-coal-fired-202220177.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BFI":"BurgerFi International, Inc."},"source_url":"https://finance.yahoo.com/news/burgerfi-acquire-anthonys-coal-fired-202220177.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2174186083","content_text":"BurgerFi International Inc (NASDAQ: BFI) has agreed to acquire Anthony's Coal Fired Pizza & Wings from private equity firm L Catterton for about $161.3 million.\nFort Lauderdale, Florida-based Anthony's, founded in 2002, is an operator of casual dining pizza restaurants.\nThe deal price comprises $33.6 million in common stock, $53.0 million in new junior non-convertible preferred equity, and the assumption of estimated $74.7 million debt, all subject to closing adjustments.\nAt the closing of the transaction, L Catterton will become one of BurgerFi's largest shareholders. Andrew Taub, a Managing Partner at L Catterton, will be joining BurgerFi's board following the completion of the transaction expected to occur in the fourth quarter of 2021.\nBurgerFi expects the transaction to be accretive to EPS to common shareholders and EBITDA in 2022.\nOphir Sternberg will lead both the BurgerFi and Anthony's brands in his continuing role of Executive Chairman of BurgerFi, and Mike Rabinovitch will continue as BurgerFi CFO.\nAt the closing of the transaction, Ian Baines will become the CEO of BurgerFi, while Julio Ramirez will remain CEO and President of the BurgerFi brand, and Patrick Renna will become President of Anthony's brand.\nBurgerFi held .75 million in cash and equivalents as of June 30, 2021.\nPrice Action: BFI shares closed higher by 5.77% at $8.43 on Monday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":588,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":828933068,"gmtCreate":1633831081657,"gmtModify":1633831081657,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good info","listText":"Good info","text":"Good info","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/828933068","repostId":"1111746159","repostType":4,"repost":{"id":"1111746159","pubTimestamp":1633760372,"share":"https://www.laohu8.com/m/news/1111746159?lang=&edition=full","pubTime":"2021-10-09 14:19","market":"us","language":"en","title":"Nikola inks hydrogen production deal with Canada's TC Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=1111746159","media":"THE BUSINESS JOURNALS","summary":"Nikola, the Phoenix-based maker of zero emission vehicles, announced a joint development agreement w","content":"<p>Nikola, the Phoenix-based maker of zero emission vehicles, announced a joint development agreement with Canada’s TC Energy on Thursday to co-develop hydrogen production facilities in the U.S. and Canada.</p>\n<p>Nikola Corp. (Nasdaq: NKLA) and Calgary, Canada-based TC Energy Corp. (TSX, NYSE: TRP) have agreed to collaborate on development, construction and operation of hydrogen hubs, with the goal of building facilities capable of producing 150 tonnes or more of hydrogen per day in the next five years.</p>\n<p>This agreement is designed to encourage the adoption of hydrogen fuel cell electric vehicles (FCEVs) by building out the necessary infrastructure to fuel these forthcoming vehicles. Nikola is still in pre-production, but the company plans to deliver its first battery electric vehicles (BEVs) by the end of this year, with first FCEVs expected by 2023.</p>\n<p>Nikola’s vehicles will fall under the Class 8 vehicle classification, for large tractor trailer trucks designed to haul freight.</p>\n<p>TC Energy is one of the largest energy companies in North America, operating natural gas pipelines, liquid pipelines and energy production businesses. TC Energy was also the company leading development of the Keystone XL pipeline, but&nbsp;officially abandoned the project&nbsp;in June.</p>\n<p>Additionally, Nikola joined other heavy duty hydrogen vehicle makers on Friday in an agreement to standardize fueling hardware components for hydrogen-powered vehicles across the globe. The goal is to create a fueling network that works with all hydrogen vehicle makers, similar to what exists today for gasoline stations.</p>\n<p>The Hydrogen Heavy Duty Vehicle Industry Group — which is comprised of Air Liquid, Hyundai, Nel Hydrogen, Shell, Toyota and Nikola — specifically signed an agreement with Tatsuno Corp. and Transfer Oil SpA on a new high flow 70 megapascal (a measurement of pressure) baseline, which has been dubbed the H70HF standard.</p>\n<p>\"This innovative fueling technology will be an essential part of our hydrogen infrastructure development strategy, making hydrogen available to Nikola heavy-duty FCEV customers and the industry at large,\" Nikola’s president of energy and commercial Pablo Koziner said in a statement.</p>\n<p>These two agreements help further illuminate Nikola’s plan to get its FCEVs out on the road, after recently signing a flurry of other hydrogen-related deals.</p>\n<p>In June Nikola said it would&nbsp;invest $50 million in a hydrogen production plant&nbsp;in Indiana, last month it signed a&nbsp;fuel cell production deal with Boschand earlier this month it signed a&nbsp;joint development agreement&nbsp;for hydrogen fueling infrastructure with OPAL Fuels.</p>\n<p>In Thursday trading, following the Nikola and TC Energy announcement, Nikola’s shares gained 46 cents (4.51%) to close at $10.67. TC Energy’s shares also rose on the news, adding 58 cents (1.19%) on Thursday to close at $49.16.Follow Nikola’s stock hereandTC Energy’s stock here.</p>\n<p><b>Milton case update</b></p>\n<p>Nikola Corp. was founded by Trevor Milton in Utah back in 2015, but he relocated the company to Arizona in 2018 with its arrival hailed as a big win by local business leaders.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8f7b9c77b869e2ea569c297cc098a120\" tg-width=\"750\" tg-height=\"422\" width=\"100%\" height=\"auto\"><span>A file photo of former Nikola Corp. CEO Trevor Milton. JIM POULIN | PHOENIX BUSINESS JOURNAL</span></p>\n<p>Last year Hindenburg Research, a short seller, publisheda reportthat described Nikola as an “intricate fraud,\" leading toMilton's resignationless than two weeks later. Though he is no longer running the company, Milton is still a major shareholder at Nikola.</p>\n<p>In July, Milton was chargedwith securities fraudin the Southern District of New York. The Securities and Exchange Commission also charged Milton with violating the anti-fraud provisions and accused him of repeatedly disseminating false and misleading information.</p>\n<p>“[Milton] engaged in a fraudulent scheme to deceive retail investors about Nikola’s products, technical advancements, and commercial prospects for his own personal benefit,”the SEC complaintread. “Milton did so primarily by leveraging his social media presence and frequent appearances on television and podcasts to flood the market with false and misleading information about Nikola.”</p>\n<p>Milton was released on a $100 million bond in July and his lawyer reportedly asked the judge to move the case out of New York and back to Arizona at a hearing last month,according to Law360. The court has yet to upload transcripts from the Sept. 15 hearing in which Bradley Bondi, Milton’s lawyer, requested the shift in venue. Milton's trial is expected to start in April 2022.</p>","source":"lsy1633760424806","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nikola inks hydrogen production deal with Canada's TC Energy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNikola inks hydrogen production deal with Canada's TC Energy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-09 14:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bizjournals.com/phoenix/news/2021/10/08/nikola-tc-energy-hydrogen-production.html?ana=yahoo><strong>THE BUSINESS JOURNALS</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nikola, the Phoenix-based maker of zero emission vehicles, announced a joint development agreement with Canada’s TC Energy on Thursday to co-develop hydrogen production facilities in the U.S. and ...</p>\n\n<a href=\"https://www.bizjournals.com/phoenix/news/2021/10/08/nikola-tc-energy-hydrogen-production.html?ana=yahoo\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NKLA":"Nikola Corporation"},"source_url":"https://www.bizjournals.com/phoenix/news/2021/10/08/nikola-tc-energy-hydrogen-production.html?ana=yahoo","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111746159","content_text":"Nikola, the Phoenix-based maker of zero emission vehicles, announced a joint development agreement with Canada’s TC Energy on Thursday to co-develop hydrogen production facilities in the U.S. and Canada.\nNikola Corp. (Nasdaq: NKLA) and Calgary, Canada-based TC Energy Corp. (TSX, NYSE: TRP) have agreed to collaborate on development, construction and operation of hydrogen hubs, with the goal of building facilities capable of producing 150 tonnes or more of hydrogen per day in the next five years.\nThis agreement is designed to encourage the adoption of hydrogen fuel cell electric vehicles (FCEVs) by building out the necessary infrastructure to fuel these forthcoming vehicles. Nikola is still in pre-production, but the company plans to deliver its first battery electric vehicles (BEVs) by the end of this year, with first FCEVs expected by 2023.\nNikola’s vehicles will fall under the Class 8 vehicle classification, for large tractor trailer trucks designed to haul freight.\nTC Energy is one of the largest energy companies in North America, operating natural gas pipelines, liquid pipelines and energy production businesses. TC Energy was also the company leading development of the Keystone XL pipeline, but officially abandoned the project in June.\nAdditionally, Nikola joined other heavy duty hydrogen vehicle makers on Friday in an agreement to standardize fueling hardware components for hydrogen-powered vehicles across the globe. The goal is to create a fueling network that works with all hydrogen vehicle makers, similar to what exists today for gasoline stations.\nThe Hydrogen Heavy Duty Vehicle Industry Group — which is comprised of Air Liquid, Hyundai, Nel Hydrogen, Shell, Toyota and Nikola — specifically signed an agreement with Tatsuno Corp. and Transfer Oil SpA on a new high flow 70 megapascal (a measurement of pressure) baseline, which has been dubbed the H70HF standard.\n\"This innovative fueling technology will be an essential part of our hydrogen infrastructure development strategy, making hydrogen available to Nikola heavy-duty FCEV customers and the industry at large,\" Nikola’s president of energy and commercial Pablo Koziner said in a statement.\nThese two agreements help further illuminate Nikola’s plan to get its FCEVs out on the road, after recently signing a flurry of other hydrogen-related deals.\nIn June Nikola said it would invest $50 million in a hydrogen production plant in Indiana, last month it signed a fuel cell production deal with Boschand earlier this month it signed a joint development agreement for hydrogen fueling infrastructure with OPAL Fuels.\nIn Thursday trading, following the Nikola and TC Energy announcement, Nikola’s shares gained 46 cents (4.51%) to close at $10.67. TC Energy’s shares also rose on the news, adding 58 cents (1.19%) on Thursday to close at $49.16.Follow Nikola’s stock hereandTC Energy’s stock here.\nMilton case update\nNikola Corp. was founded by Trevor Milton in Utah back in 2015, but he relocated the company to Arizona in 2018 with its arrival hailed as a big win by local business leaders.\nA file photo of former Nikola Corp. CEO Trevor Milton. JIM POULIN | PHOENIX BUSINESS JOURNAL\nLast year Hindenburg Research, a short seller, publisheda reportthat described Nikola as an “intricate fraud,\" leading toMilton's resignationless than two weeks later. Though he is no longer running the company, Milton is still a major shareholder at Nikola.\nIn July, Milton was chargedwith securities fraudin the Southern District of New York. The Securities and Exchange Commission also charged Milton with violating the anti-fraud provisions and accused him of repeatedly disseminating false and misleading information.\n“[Milton] engaged in a fraudulent scheme to deceive retail investors about Nikola’s products, technical advancements, and commercial prospects for his own personal benefit,”the SEC complaintread. “Milton did so primarily by leveraging his social media presence and frequent appearances on television and podcasts to flood the market with false and misleading information about Nikola.”\nMilton was released on a $100 million bond in July and his lawyer reportedly asked the judge to move the case out of New York and back to Arizona at a hearing last month,according to Law360. The court has yet to upload transcripts from the Sept. 15 hearing in which Bradley Bondi, Milton’s lawyer, requested the shift in venue. Milton's trial is expected to start in April 2022.","news_type":1},"isVote":1,"tweetType":1,"viewCount":702,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":867787148,"gmtCreate":1633314819339,"gmtModify":1633314819405,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/867787148","repostId":"1114921615","repostType":4,"repost":{"id":"1114921615","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1633304045,"share":"https://www.laohu8.com/m/news/1114921615?lang=&edition=full","pubTime":"2021-10-04 07:34","market":"us","language":"en","title":"Top Wall Street analysts picks these 5 stocks for the fourth quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=1114921615","media":"Tiger Newspress","summary":"TipRanks is a financial data aggregator that uses its dynamic system like a radar, picking up what W","content":"<p>TipRanks is a financial data aggregator that uses its dynamic system like a radar, picking up what Wall Street’s analysts have to say about the current market atmosphere. The state of capital markets remains a tangled world of information for even savvy investors, but by using TipRanks’ unique tools, one can gain a clearer perspective on what the professionals are saying.</p>\n<p>Let’s take a look at what their hypotheses are on these five stocks.</p>\n<p><b><a href=\"https://laohu8.com/S/NKE\">耐克</a> </b></p>\n<p>If viewed correctly, short-term concerns have the potential to be transformed into long-term gains.</p>\n<p>Nike(<b>NKE</b>) recently reported earnings, and while it showed increases in demand and strong underlying business fundamentals, the firm did admit to struggling with persisting supply chain issues. Sam Poser of Williams Trading, however, sees this as the time to open a bullish position. (SeeNike stock chartson TipRanks)</p>\n<p>Poser rated the stock a Buy, and declared a price target of $196.</p>\n<p>The five-star analyst asserted that despite the supply chain challenges, “the global health of the Nike brand has never been better.” He perceives the headwinds to be of short-lived concern for investors and the company, and expects Nike to outperform its peers in both the near and distant future.</p>\n<p>In its earnings call, Nike lowered its guidance expectations, but Poser calculates that the apparel retailer is on track to meet 2025 targets.</p>\n<p>The Covid-19 pandemic had initially dragged down brick and mortar store sales, but this metric has nearly rebounded to the status it held before the government-mandated lockdowns. In North America, in-store sales increased more than 50% quarter-over-quarter, indicating a “robust demand” for Nike merchandise.</p>\n<p>In a pool of over 7,000 expert analysts, Poser is rated by TipRanks as No. 249. His stock ratings have earned him a success rate of 55%, and brought him an average return of 24.8%.</p>\n<p><b><a href=\"https://laohu8.com/S/OTMO\">Otonomo Technologies Ltd</a> </b></p>\n<p>For SaaS companies, big data is the name of the game.</p>\n<p>The power of processing billions of data points from millions of vehicles on the road has provided Otonomo Technologies (<b>OTMO</b>) with a promising business model. The data analytics firm recently went public, and analysts now see even more upside and opportunity for monetization of its product offerings. (SeeOtonomo stock analysison TipRanks)</p>\n<p>One of those bullish analysts is Jack Andrews of Needham &amp; Co., who wrote thatOtonomooperates a “linchpin technology” that unlocks revenue for original equipment manufacturer and connected car investments.” From his calculations, the stock provides a “favorable risk/reward setup with material upside,” if it is successful in capturing its full potential.</p>\n<p>Andrews initiated a Buy rating on the stock, and determined a 12-month price target of $10 per share.</p>\n<p>The top analyst explained that the company has created a bridge between two promising sectors: automotive data and its analytics. As connected car prevalence increases, so do the number of possible applications for the data they generate. He noted that beyond major car manufacturers, new revenue opportunities could arise from insurance companies and concierge platforms incorporating OTMO’s data.</p>\n<p>In addition to enterprise players, Otonomo provides intelligence for municipal governments about how to design safer and more efficient urban plans.</p>\n<p>One concern for the firm is a potential regulatory shift toward consumer privacy of the information shared by the vehicles, which would disrupt OTMO’s standards of data.</p>\n<p>Out of more than 7,000 analysts on TipRanks, Andrews ranks as No.158. Of his ratings, he succeeded 63% of the time, and returned an average of 25.3% on each one.</p>\n<p><b><a href=\"https://laohu8.com/S/VAC\">Marriott Vacations Worldwide</a> </b></p>\n<p>The Covid-19 pandemic has proved a formidable foe for the travel and leisure industry. After repeated government mandated shutdowns, the delta variant arrived late spring and caused more disruption. Marriot Vacations Worldwide (<b>VAC</b>) survived the storm, and is remaining relevant even in the current dynamic climate.</p>\n<p>David Katz of Jefferies asserted that the company is poised for upside, and is one of his top stock picks for the leisure industry. (SeeMarriot Vacations insider trading activityon TipRanks)</p>\n<p>Katz rated the stock a Buy, and assigned a 12-month price target of $190.</p>\n<p>This bullish target takes into account headwinds from Covid-19, as well as ongoing wildfires across the western U.S. He expects the built-up consumer demand for vacations and timeshares to lead the company toward recovering from its pandemic-induced losses.</p>\n<p>While the entire industry is set to experience this strong demand, Katz believes thatVAC’s links to Marriot International (<b>MAR</b>) and its brand awareness set it apart from the competition. Additionally, this connection gives VAC “access to the largest loyalty program in hospitality,” providing the firm with a massive installed base.</p>\n<p>On TipRanks, Katz comes in at No. 418 out of more than 7,000 financial analysts. From his ratings, he was successful 62% of the time, and brought in an average return of 21% per rating.</p>\n<p><b>Dell Technologies<a href=\"https://laohu8.com/S/DELL\">$(DELL)$</a> </b></p>\n<p>Dell Technologies(<b>DELL</b>) recently held its pivotal investor day, and laid out a clear roadmap to increasing free cash flow, market share, and general direction for the company in the long-term. Share repurchasing schemes, a focus on premium consumer products, and potential upside in infrastructure projects, all point the multinational tech firm toward an eventual higher valuation.</p>\n<p>Amit Daryanani of Evercore ISI reported on the conference, bullishly reiterating a Buy rating and a 12-month $114 price target.</p>\n<p>Daryanani explained that Dell announced a share repurchase program worth $5 billion in stock, as well as a quarterly dividend. In an effort to increase free cash flow, the tech company will keep its investments in mergers and acquisitions at a less significant profile. The analyst said that the conference sentiment was on-par to above his expectations. (SeeDell Technologies risk factorson TipRanks)</p>\n<p>Dell’s infrastructure and cloud-based storage facing businesses could see “substantial opportunity” in the long-term, such as in remote access solutions and telecommunications software. The Covid-19 pandemic and the work-from-home shift bolstered trends toward PCs and gaming hardware. Dell understands this and intends to focus on more premium products for everyday consumers.</p>\n<p>Ranking No. 355 out of over 7,000 analysts on TipRanks, Daryanani maintains a 63% success rate on his ratings. His stock picks currently average out to a 16.6% return.</p>\n<p><b>Activision Blizzard</b><b><a href=\"https://laohu8.com/S/ATVI\">$(ATVI)$</a> </b></p>\n<p>While individuals were under pandemic-induced lockdowns, many people picked up playing video games as a way to pass the time. The companies that produce these game franchises benefitted from the trend, andActivision Blizzard(<b>ATVI</b>) was no outlier. Now, the firm has a “wave of content” headed to consumers’ consoles, and analysts are bullish on the strong pipeline.</p>\n<p>Andrew Uerkwitz of Jefferies delineated his bullish hypothesis on the stock, stating that Activision has an “underappreciated portfolio of high-quality content in the fastest growing segment in entertainment.”</p>\n<p>Uerkwitz declared the stock a Buy, and assigned a 12-month price target of $120 per share.</p>\n<p>After running several possible scenarios regarding release dates and consumer reception for its upcoming titles, the five-star analyst still finds it hard to imagine further downside, even in bearish cases. Uerkwitz calculated a situation wherein a particular title underperformed, and Activision Blizzard still exceeded estimates for FY2021 earnings per share. (SeeActivision Blizzard’s earnings historyon TipRanks)</p>\n<p>The company maintains strong gross margins, which are providing it with significant operating leverage. Elaborating on Activision’s options, Uerkwitz added that it has tools for growth, such as share buyback schemes and investments in content, and can explore inorganic expansion through mergers and acquisitions.</p>\n<p>Activision recently came to a settlement with the Equal Employment Opportunity Commission regarding a sexual harassment case. In his opinion, Uerkwitz sees the $18 million deal with the U.S. federal agency as a speed bump in an otherwise smooth year. The settlement removes concerns over worse regulatory penalties, although a less-than-stellar work environment could prove as downside if talent is to be driven away.</p>\n<p>On TipRanks, Uerkwitz maintains a rank of No. 122 out of over 7,000 expert analysts. His success rate stands at 62%, and per rating he averages a return of 27.7%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Wall Street analysts picks these 5 stocks for the fourth quarter</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Wall Street analysts picks these 5 stocks for the fourth quarter\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-04 07:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TipRanks is a financial data aggregator that uses its dynamic system like a radar, picking up what Wall Street’s analysts have to say about the current market atmosphere. The state of capital markets remains a tangled world of information for even savvy investors, but by using TipRanks’ unique tools, one can gain a clearer perspective on what the professionals are saying.</p>\n<p>Let’s take a look at what their hypotheses are on these five stocks.</p>\n<p><b><a href=\"https://laohu8.com/S/NKE\">耐克</a> </b></p>\n<p>If viewed correctly, short-term concerns have the potential to be transformed into long-term gains.</p>\n<p>Nike(<b>NKE</b>) recently reported earnings, and while it showed increases in demand and strong underlying business fundamentals, the firm did admit to struggling with persisting supply chain issues. Sam Poser of Williams Trading, however, sees this as the time to open a bullish position. (SeeNike stock chartson TipRanks)</p>\n<p>Poser rated the stock a Buy, and declared a price target of $196.</p>\n<p>The five-star analyst asserted that despite the supply chain challenges, “the global health of the Nike brand has never been better.” He perceives the headwinds to be of short-lived concern for investors and the company, and expects Nike to outperform its peers in both the near and distant future.</p>\n<p>In its earnings call, Nike lowered its guidance expectations, but Poser calculates that the apparel retailer is on track to meet 2025 targets.</p>\n<p>The Covid-19 pandemic had initially dragged down brick and mortar store sales, but this metric has nearly rebounded to the status it held before the government-mandated lockdowns. In North America, in-store sales increased more than 50% quarter-over-quarter, indicating a “robust demand” for Nike merchandise.</p>\n<p>In a pool of over 7,000 expert analysts, Poser is rated by TipRanks as No. 249. His stock ratings have earned him a success rate of 55%, and brought him an average return of 24.8%.</p>\n<p><b><a href=\"https://laohu8.com/S/OTMO\">Otonomo Technologies Ltd</a> </b></p>\n<p>For SaaS companies, big data is the name of the game.</p>\n<p>The power of processing billions of data points from millions of vehicles on the road has provided Otonomo Technologies (<b>OTMO</b>) with a promising business model. The data analytics firm recently went public, and analysts now see even more upside and opportunity for monetization of its product offerings. (SeeOtonomo stock analysison TipRanks)</p>\n<p>One of those bullish analysts is Jack Andrews of Needham &amp; Co., who wrote thatOtonomooperates a “linchpin technology” that unlocks revenue for original equipment manufacturer and connected car investments.” From his calculations, the stock provides a “favorable risk/reward setup with material upside,” if it is successful in capturing its full potential.</p>\n<p>Andrews initiated a Buy rating on the stock, and determined a 12-month price target of $10 per share.</p>\n<p>The top analyst explained that the company has created a bridge between two promising sectors: automotive data and its analytics. As connected car prevalence increases, so do the number of possible applications for the data they generate. He noted that beyond major car manufacturers, new revenue opportunities could arise from insurance companies and concierge platforms incorporating OTMO’s data.</p>\n<p>In addition to enterprise players, Otonomo provides intelligence for municipal governments about how to design safer and more efficient urban plans.</p>\n<p>One concern for the firm is a potential regulatory shift toward consumer privacy of the information shared by the vehicles, which would disrupt OTMO’s standards of data.</p>\n<p>Out of more than 7,000 analysts on TipRanks, Andrews ranks as No.158. Of his ratings, he succeeded 63% of the time, and returned an average of 25.3% on each one.</p>\n<p><b><a href=\"https://laohu8.com/S/VAC\">Marriott Vacations Worldwide</a> </b></p>\n<p>The Covid-19 pandemic has proved a formidable foe for the travel and leisure industry. After repeated government mandated shutdowns, the delta variant arrived late spring and caused more disruption. Marriot Vacations Worldwide (<b>VAC</b>) survived the storm, and is remaining relevant even in the current dynamic climate.</p>\n<p>David Katz of Jefferies asserted that the company is poised for upside, and is one of his top stock picks for the leisure industry. (SeeMarriot Vacations insider trading activityon TipRanks)</p>\n<p>Katz rated the stock a Buy, and assigned a 12-month price target of $190.</p>\n<p>This bullish target takes into account headwinds from Covid-19, as well as ongoing wildfires across the western U.S. He expects the built-up consumer demand for vacations and timeshares to lead the company toward recovering from its pandemic-induced losses.</p>\n<p>While the entire industry is set to experience this strong demand, Katz believes thatVAC’s links to Marriot International (<b>MAR</b>) and its brand awareness set it apart from the competition. Additionally, this connection gives VAC “access to the largest loyalty program in hospitality,” providing the firm with a massive installed base.</p>\n<p>On TipRanks, Katz comes in at No. 418 out of more than 7,000 financial analysts. From his ratings, he was successful 62% of the time, and brought in an average return of 21% per rating.</p>\n<p><b>Dell Technologies<a href=\"https://laohu8.com/S/DELL\">$(DELL)$</a> </b></p>\n<p>Dell Technologies(<b>DELL</b>) recently held its pivotal investor day, and laid out a clear roadmap to increasing free cash flow, market share, and general direction for the company in the long-term. Share repurchasing schemes, a focus on premium consumer products, and potential upside in infrastructure projects, all point the multinational tech firm toward an eventual higher valuation.</p>\n<p>Amit Daryanani of Evercore ISI reported on the conference, bullishly reiterating a Buy rating and a 12-month $114 price target.</p>\n<p>Daryanani explained that Dell announced a share repurchase program worth $5 billion in stock, as well as a quarterly dividend. In an effort to increase free cash flow, the tech company will keep its investments in mergers and acquisitions at a less significant profile. The analyst said that the conference sentiment was on-par to above his expectations. (SeeDell Technologies risk factorson TipRanks)</p>\n<p>Dell’s infrastructure and cloud-based storage facing businesses could see “substantial opportunity” in the long-term, such as in remote access solutions and telecommunications software. The Covid-19 pandemic and the work-from-home shift bolstered trends toward PCs and gaming hardware. Dell understands this and intends to focus on more premium products for everyday consumers.</p>\n<p>Ranking No. 355 out of over 7,000 analysts on TipRanks, Daryanani maintains a 63% success rate on his ratings. His stock picks currently average out to a 16.6% return.</p>\n<p><b>Activision Blizzard</b><b><a href=\"https://laohu8.com/S/ATVI\">$(ATVI)$</a> </b></p>\n<p>While individuals were under pandemic-induced lockdowns, many people picked up playing video games as a way to pass the time. The companies that produce these game franchises benefitted from the trend, andActivision Blizzard(<b>ATVI</b>) was no outlier. Now, the firm has a “wave of content” headed to consumers’ consoles, and analysts are bullish on the strong pipeline.</p>\n<p>Andrew Uerkwitz of Jefferies delineated his bullish hypothesis on the stock, stating that Activision has an “underappreciated portfolio of high-quality content in the fastest growing segment in entertainment.”</p>\n<p>Uerkwitz declared the stock a Buy, and assigned a 12-month price target of $120 per share.</p>\n<p>After running several possible scenarios regarding release dates and consumer reception for its upcoming titles, the five-star analyst still finds it hard to imagine further downside, even in bearish cases. Uerkwitz calculated a situation wherein a particular title underperformed, and Activision Blizzard still exceeded estimates for FY2021 earnings per share. (SeeActivision Blizzard’s earnings historyon TipRanks)</p>\n<p>The company maintains strong gross margins, which are providing it with significant operating leverage. Elaborating on Activision’s options, Uerkwitz added that it has tools for growth, such as share buyback schemes and investments in content, and can explore inorganic expansion through mergers and acquisitions.</p>\n<p>Activision recently came to a settlement with the Equal Employment Opportunity Commission regarding a sexual harassment case. In his opinion, Uerkwitz sees the $18 million deal with the U.S. federal agency as a speed bump in an otherwise smooth year. The settlement removes concerns over worse regulatory penalties, although a less-than-stellar work environment could prove as downside if talent is to be driven away.</p>\n<p>On TipRanks, Uerkwitz maintains a rank of No. 122 out of over 7,000 expert analysts. His success rate stands at 62%, and per rating he averages a return of 27.7%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114921615","content_text":"TipRanks is a financial data aggregator that uses its dynamic system like a radar, picking up what Wall Street’s analysts have to say about the current market atmosphere. The state of capital markets remains a tangled world of information for even savvy investors, but by using TipRanks’ unique tools, one can gain a clearer perspective on what the professionals are saying.\nLet’s take a look at what their hypotheses are on these five stocks.\n耐克 \nIf viewed correctly, short-term concerns have the potential to be transformed into long-term gains.\nNike(NKE) recently reported earnings, and while it showed increases in demand and strong underlying business fundamentals, the firm did admit to struggling with persisting supply chain issues. Sam Poser of Williams Trading, however, sees this as the time to open a bullish position. (SeeNike stock chartson TipRanks)\nPoser rated the stock a Buy, and declared a price target of $196.\nThe five-star analyst asserted that despite the supply chain challenges, “the global health of the Nike brand has never been better.” He perceives the headwinds to be of short-lived concern for investors and the company, and expects Nike to outperform its peers in both the near and distant future.\nIn its earnings call, Nike lowered its guidance expectations, but Poser calculates that the apparel retailer is on track to meet 2025 targets.\nThe Covid-19 pandemic had initially dragged down brick and mortar store sales, but this metric has nearly rebounded to the status it held before the government-mandated lockdowns. In North America, in-store sales increased more than 50% quarter-over-quarter, indicating a “robust demand” for Nike merchandise.\nIn a pool of over 7,000 expert analysts, Poser is rated by TipRanks as No. 249. His stock ratings have earned him a success rate of 55%, and brought him an average return of 24.8%.\nOtonomo Technologies Ltd \nFor SaaS companies, big data is the name of the game.\nThe power of processing billions of data points from millions of vehicles on the road has provided Otonomo Technologies (OTMO) with a promising business model. The data analytics firm recently went public, and analysts now see even more upside and opportunity for monetization of its product offerings. (SeeOtonomo stock analysison TipRanks)\nOne of those bullish analysts is Jack Andrews of Needham & Co., who wrote thatOtonomooperates a “linchpin technology” that unlocks revenue for original equipment manufacturer and connected car investments.” From his calculations, the stock provides a “favorable risk/reward setup with material upside,” if it is successful in capturing its full potential.\nAndrews initiated a Buy rating on the stock, and determined a 12-month price target of $10 per share.\nThe top analyst explained that the company has created a bridge between two promising sectors: automotive data and its analytics. As connected car prevalence increases, so do the number of possible applications for the data they generate. He noted that beyond major car manufacturers, new revenue opportunities could arise from insurance companies and concierge platforms incorporating OTMO’s data.\nIn addition to enterprise players, Otonomo provides intelligence for municipal governments about how to design safer and more efficient urban plans.\nOne concern for the firm is a potential regulatory shift toward consumer privacy of the information shared by the vehicles, which would disrupt OTMO’s standards of data.\nOut of more than 7,000 analysts on TipRanks, Andrews ranks as No.158. Of his ratings, he succeeded 63% of the time, and returned an average of 25.3% on each one.\nMarriott Vacations Worldwide \nThe Covid-19 pandemic has proved a formidable foe for the travel and leisure industry. After repeated government mandated shutdowns, the delta variant arrived late spring and caused more disruption. Marriot Vacations Worldwide (VAC) survived the storm, and is remaining relevant even in the current dynamic climate.\nDavid Katz of Jefferies asserted that the company is poised for upside, and is one of his top stock picks for the leisure industry. (SeeMarriot Vacations insider trading activityon TipRanks)\nKatz rated the stock a Buy, and assigned a 12-month price target of $190.\nThis bullish target takes into account headwinds from Covid-19, as well as ongoing wildfires across the western U.S. He expects the built-up consumer demand for vacations and timeshares to lead the company toward recovering from its pandemic-induced losses.\nWhile the entire industry is set to experience this strong demand, Katz believes thatVAC’s links to Marriot International (MAR) and its brand awareness set it apart from the competition. Additionally, this connection gives VAC “access to the largest loyalty program in hospitality,” providing the firm with a massive installed base.\nOn TipRanks, Katz comes in at No. 418 out of more than 7,000 financial analysts. From his ratings, he was successful 62% of the time, and brought in an average return of 21% per rating.\nDell Technologies$(DELL)$ \nDell Technologies(DELL) recently held its pivotal investor day, and laid out a clear roadmap to increasing free cash flow, market share, and general direction for the company in the long-term. Share repurchasing schemes, a focus on premium consumer products, and potential upside in infrastructure projects, all point the multinational tech firm toward an eventual higher valuation.\nAmit Daryanani of Evercore ISI reported on the conference, bullishly reiterating a Buy rating and a 12-month $114 price target.\nDaryanani explained that Dell announced a share repurchase program worth $5 billion in stock, as well as a quarterly dividend. In an effort to increase free cash flow, the tech company will keep its investments in mergers and acquisitions at a less significant profile. The analyst said that the conference sentiment was on-par to above his expectations. (SeeDell Technologies risk factorson TipRanks)\nDell’s infrastructure and cloud-based storage facing businesses could see “substantial opportunity” in the long-term, such as in remote access solutions and telecommunications software. The Covid-19 pandemic and the work-from-home shift bolstered trends toward PCs and gaming hardware. Dell understands this and intends to focus on more premium products for everyday consumers.\nRanking No. 355 out of over 7,000 analysts on TipRanks, Daryanani maintains a 63% success rate on his ratings. His stock picks currently average out to a 16.6% return.\nActivision Blizzard$(ATVI)$ \nWhile individuals were under pandemic-induced lockdowns, many people picked up playing video games as a way to pass the time. The companies that produce these game franchises benefitted from the trend, andActivision Blizzard(ATVI) was no outlier. Now, the firm has a “wave of content” headed to consumers’ consoles, and analysts are bullish on the strong pipeline.\nAndrew Uerkwitz of Jefferies delineated his bullish hypothesis on the stock, stating that Activision has an “underappreciated portfolio of high-quality content in the fastest growing segment in entertainment.”\nUerkwitz declared the stock a Buy, and assigned a 12-month price target of $120 per share.\nAfter running several possible scenarios regarding release dates and consumer reception for its upcoming titles, the five-star analyst still finds it hard to imagine further downside, even in bearish cases. Uerkwitz calculated a situation wherein a particular title underperformed, and Activision Blizzard still exceeded estimates for FY2021 earnings per share. (SeeActivision Blizzard’s earnings historyon TipRanks)\nThe company maintains strong gross margins, which are providing it with significant operating leverage. Elaborating on Activision’s options, Uerkwitz added that it has tools for growth, such as share buyback schemes and investments in content, and can explore inorganic expansion through mergers and acquisitions.\nActivision recently came to a settlement with the Equal Employment Opportunity Commission regarding a sexual harassment case. In his opinion, Uerkwitz sees the $18 million deal with the U.S. federal agency as a speed bump in an otherwise smooth year. The settlement removes concerns over worse regulatory penalties, although a less-than-stellar work environment could prove as downside if talent is to be driven away.\nOn TipRanks, Uerkwitz maintains a rank of No. 122 out of over 7,000 expert analysts. His success rate stands at 62%, and per rating he averages a return of 27.7%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":269,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":867219986,"gmtCreate":1633270125073,"gmtModify":1633270125185,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Yes offcourse&nbsp;","listText":"Yes offcourse&nbsp;","text":"Yes offcourse","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/867219986","repostId":"2172962172","repostType":4,"isVote":1,"tweetType":1,"viewCount":298,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865409165,"gmtCreate":1633008480605,"gmtModify":1633008480687,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good info","listText":"Good info","text":"Good info","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865409165","repostId":"1130437913","repostType":4,"isVote":1,"tweetType":1,"viewCount":426,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865400406,"gmtCreate":1633008440042,"gmtModify":1633008440180,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865400406","repostId":"2171937752","repostType":4,"repost":{"id":"2171937752","pubTimestamp":1633002256,"share":"https://www.laohu8.com/m/news/2171937752?lang=&edition=full","pubTime":"2021-09-30 19:44","market":"us","language":"en","title":"4 Stocks Expected to Increase Sales 25,750% to 2,970,000% in 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2171937752","media":"Motley Fool","summary":"These companies could deliver jaw-dropping revenue growth through mid-decade.","content":"<p>High-growth stocks have dominated Wall Street for more than a decade -- and with good reason. Historically low lending rates and an accommodative monetary policy have paved the way for fast-paced companies to borrow at attractive rates.</p>\n<p>But for some companies, sales growth is about to kick into high gear. When you're building a business from the ground up, going from practically nothing in sales to hundreds of millions or billions of dollars in revenue in just a couple of years can be a jaw-dropping experience.</p>\n<p>The following four companies are expected to do just that. According to Wall Street's consensus estimates, these four stocks are forecast to increase sales by 25,750% to as much as 2,970,000% (that's nearly 3 million percent) over the next five years.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ee55796575e48ba3143c099af095e386\" tg-width=\"700\" tg-height=\"535\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Vaxart: 25,752% implied sales growth by 2025</h2>\n<p>A clinical-stage biotech stock angling for its first approved therapy is a perfect example of a business that could grow from a relatively small amount of non-recurring revenue to a considerably larger sum of recurring sales. Drug-developer <b>Vaxart</b> (NASDAQ:VXRT) is expected to increase its annual sales from the $4.05 million reported in 2020 to a consensus estimate of $1.047 billion by mid-decade. That's an increase of about 25,750%, if Wall Street's numbers prove accurate.</p>\n<p>Vaxart's future is pinned to the success of its VAAST platform. \"VAAST\" stands for Vector-Adjuvant-Antigen Standardized Technology and encompasses the company's attempts to develop proprietary oral vaccines. Whereas standard vaccines administered in a shot can activate systemic immunity, oral-vaccine tablets would be designed to activate systemic and mucosal immunity in the intestines, lungs, nose, and mouth. In other words, this dual-action approach could carry better immunity against potentially deadly viruses.</p>\n<p>The oral vaccine that's arguably received the most attention for Vaxart is VXA-CoV2-1, an early-stage tablet designed to combat the coronavirus disease 2019 (COVID-19). In May, Vaxart announced that its phase 1 study of VXA-CoV2-1 led to clear immune response in participants, although high levels of neutralizing antibodies weren't present. Traditional shot-in-the-arm vaccines have led to high levels of neutralizing antibodies in clinical trials.</p>\n<p>But Vaxart's work isn't close to being finished. In early August, it received the go-ahead from the U.S. Food and Drug Administration (FDA) to commence an oral-tablet study for a very specific protein to combat COVID-19. It could be some time before investors know if oral vaccines are a viable solution, but the convenience factor certainly makes this trial worth watching.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/650d01a926fded89c361069c76a528f5\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>CRISPR Technologies: 191,416% implied sales growth by 2025</h2>\n<p>Did I mention that clinical-stage biotech stocks are a great source of jaw-dropping growth over the next decade? <b>CRISPR Therapeutics</b> (NASDAQ:CRSP), a company leaning on gene-editing technology to precisely alter genomic DNA and tackle hard-to-treat diseases, is expected to see sales climb from $719,000 in 2020 to a consensus of $1.377 billion by 2025. That's an improvement of more than 191,000% in five years.</p>\n<p>Arguably the biggest positive for CRISPR is that it's working with <b>Vertex Pharmaceuticals</b> (NASDAQ:VRTX) in the development of CTX001 for the treatment of transfusion-dependent beta thalassemia (TDT) and sickle cell disease (SCD). Vertex has a storied history of developing novel therapies for hard-to-treat illnesses, such as cystic fibrosis.</p>\n<p>It also doesn't hurt that Vertex's deep pockets are helping to lift CRISPR's bank account. Following a $900 million collaboration payment in the second quarter, CRISPR was sitting on nearly $2.6 billion in cash, cash equivalents, and marketable securities. That's plenty of capital to fund its ongoing clinical studies.</p>\n<p>Initial trial data for CTX001 has also been encouraging. At the European Hematology Association's annual meeting in June, the company announced that all 15 patients with TDT were transfusion-free after follow-ups of at least three months. TDT patients can require weekly transfusions, depending on the severity of their illnesses. Management believes regulatory filings, assuming all goes well in clinical studies, could come by or before mid-2023.</p>\n<p>While CRISPR Technologies is far from the only company looking to tackle TDT and SCD, it's among the best funded and has Vertex in its corner. That gives it a better-than-average chance of success, at least in my book.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a38605bee8e62f3e8aa414fa24278e7e\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Ocugen: 604,551% implied sales growth by 2025</h2>\n<p>Yet another clinical-stage biotech company expected to see sales go from virtually zero to a big number with a lot of zeroes is <b>Ocugen</b> (NASDAQ:OCGN). After the company reported $43,000 in sales last year, Wall Street's consensus has it generating $260 million in full-year sales by 2025. We're talking about a nearly 605,000% sales increase in five years.</p>\n<p>Not to sound like a broken record, but a COVID-19 vaccine is Ocugen's potential catalyst. The company has partnered with India's Bharat Biotech for the commercialization of Covaxin. A phase 3 trial of 25,800 adults aged 18 and up in India demonstrated a vaccine efficacy of 77.8% for symptomatic infections, 63.6% against asymptomatic infections, and most importantly was 93.4% effective against severe COVID-19 disease. The July-reported data from Bharat also showed a 65.2% efficacy against the delta variant.</p>\n<p>With so many people left to be vaccinated, this probably sounds like a slam-dunk for some form of emergency authorization use in developed or emerging markets. However, there's a big problem for Ocugen: It only has co-commercialization rights for Covaxin in the U.S. and Canada. The U.S. has ordered more-than-enough vaccines to inoculate all eligible Americans, and likely has doses in reserve should booster shots become necessary. The same could be said for Canada, which invested heavily in vaccine purchases.</p>\n<p>While there's no such thing as having too many vaccine options during a pandemic, Covaxin's initial efficacy doesn't pop quite like the vaccines from <b>Moderna</b>, <b>Pfizer</b>/<b>BioNTech</b>, or even <b>Novavax</b>, which looks to be nearing its own emergency use authorization in the United States. Suffice it to say, Ocugen's sales forecast may prove unattainable.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/deae33b8912cffd8d0ba896164abff66\" tg-width=\"700\" tg-height=\"378\" width=\"100%\" height=\"auto\"><span>A rendering of the all-electric Nikola Tre semi. Image source: Nikola.</span></p>\n<h2>Nikola: 2,970,426% implied sales growth by 2025</h2>\n<p>However, the crème de la crème of growth opportunities, at least pertaining to this list, is electric vehicle (EV) manufacturer <b>Nikola</b> (NASDAQ:NKLA). The expectation is that we'll see Nikola's sales catapult from a reported $95,000 in 2020 to a consensus of $2.822 billion by 2025. This equates to almost a 3 million percent jump in annual revenue.</p>\n<p>The growth opportunity for EVs is pretty straightforward. With developed countries like the U.S. tackling climate change head-on, replacing fossil-fuel-burning vehicles with alternative-energy vehicles is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the easiest ways to make a difference. It's going to take decades for consumers and businesses to make this shift, which leaves plenty of room for multiple EV manufacturers to thrive.</p>\n<p>The issue for Nikola is that it's dealing with a public relations mess. Last year, short-side firm Hindenburg Research released a report that alleged Nikola was a fraud. Even though an independent review found that many of Hindenburg's allegations weren't true, it was discovered that founder Trevor Milton's statements regarding pre-sells weren't accurate.</p>\n<p>Despite stepping down last year, Milton was indicted by the U.S. Department of Justice on three charges of misleading investors. Ultimately, Nikola will have to overcome a breach of trust to sell its vehicles, and it likely will need a lot more cash than it has now to build up its production. Personally, I'm skeptical the company will reach this lofty sales consensus by mid-decade.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Stocks Expected to Increase Sales 25,750% to 2,970,000% in 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Stocks Expected to Increase Sales 25,750% to 2,970,000% in 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-30 19:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/30/4-stocks-increase-sales-25750-to-2970000-5-years/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>High-growth stocks have dominated Wall Street for more than a decade -- and with good reason. Historically low lending rates and an accommodative monetary policy have paved the way for fast-paced ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/30/4-stocks-increase-sales-25750-to-2970000-5-years/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NKLA":"Nikola Corporation","VXRT":"Vaxart, Inc","OCGN":"Ocugen","CRSP":"CRISPR Therapeutics AG"},"source_url":"https://www.fool.com/investing/2021/09/30/4-stocks-increase-sales-25750-to-2970000-5-years/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2171937752","content_text":"High-growth stocks have dominated Wall Street for more than a decade -- and with good reason. Historically low lending rates and an accommodative monetary policy have paved the way for fast-paced companies to borrow at attractive rates.\nBut for some companies, sales growth is about to kick into high gear. When you're building a business from the ground up, going from practically nothing in sales to hundreds of millions or billions of dollars in revenue in just a couple of years can be a jaw-dropping experience.\nThe following four companies are expected to do just that. According to Wall Street's consensus estimates, these four stocks are forecast to increase sales by 25,750% to as much as 2,970,000% (that's nearly 3 million percent) over the next five years.\nImage source: Getty Images.\nVaxart: 25,752% implied sales growth by 2025\nA clinical-stage biotech stock angling for its first approved therapy is a perfect example of a business that could grow from a relatively small amount of non-recurring revenue to a considerably larger sum of recurring sales. Drug-developer Vaxart (NASDAQ:VXRT) is expected to increase its annual sales from the $4.05 million reported in 2020 to a consensus estimate of $1.047 billion by mid-decade. That's an increase of about 25,750%, if Wall Street's numbers prove accurate.\nVaxart's future is pinned to the success of its VAAST platform. \"VAAST\" stands for Vector-Adjuvant-Antigen Standardized Technology and encompasses the company's attempts to develop proprietary oral vaccines. Whereas standard vaccines administered in a shot can activate systemic immunity, oral-vaccine tablets would be designed to activate systemic and mucosal immunity in the intestines, lungs, nose, and mouth. In other words, this dual-action approach could carry better immunity against potentially deadly viruses.\nThe oral vaccine that's arguably received the most attention for Vaxart is VXA-CoV2-1, an early-stage tablet designed to combat the coronavirus disease 2019 (COVID-19). In May, Vaxart announced that its phase 1 study of VXA-CoV2-1 led to clear immune response in participants, although high levels of neutralizing antibodies weren't present. Traditional shot-in-the-arm vaccines have led to high levels of neutralizing antibodies in clinical trials.\nBut Vaxart's work isn't close to being finished. In early August, it received the go-ahead from the U.S. Food and Drug Administration (FDA) to commence an oral-tablet study for a very specific protein to combat COVID-19. It could be some time before investors know if oral vaccines are a viable solution, but the convenience factor certainly makes this trial worth watching.\nImage source: Getty Images.\nCRISPR Technologies: 191,416% implied sales growth by 2025\nDid I mention that clinical-stage biotech stocks are a great source of jaw-dropping growth over the next decade? CRISPR Therapeutics (NASDAQ:CRSP), a company leaning on gene-editing technology to precisely alter genomic DNA and tackle hard-to-treat diseases, is expected to see sales climb from $719,000 in 2020 to a consensus of $1.377 billion by 2025. That's an improvement of more than 191,000% in five years.\nArguably the biggest positive for CRISPR is that it's working with Vertex Pharmaceuticals (NASDAQ:VRTX) in the development of CTX001 for the treatment of transfusion-dependent beta thalassemia (TDT) and sickle cell disease (SCD). Vertex has a storied history of developing novel therapies for hard-to-treat illnesses, such as cystic fibrosis.\nIt also doesn't hurt that Vertex's deep pockets are helping to lift CRISPR's bank account. Following a $900 million collaboration payment in the second quarter, CRISPR was sitting on nearly $2.6 billion in cash, cash equivalents, and marketable securities. That's plenty of capital to fund its ongoing clinical studies.\nInitial trial data for CTX001 has also been encouraging. At the European Hematology Association's annual meeting in June, the company announced that all 15 patients with TDT were transfusion-free after follow-ups of at least three months. TDT patients can require weekly transfusions, depending on the severity of their illnesses. Management believes regulatory filings, assuming all goes well in clinical studies, could come by or before mid-2023.\nWhile CRISPR Technologies is far from the only company looking to tackle TDT and SCD, it's among the best funded and has Vertex in its corner. That gives it a better-than-average chance of success, at least in my book.\nImage source: Getty Images.\nOcugen: 604,551% implied sales growth by 2025\nYet another clinical-stage biotech company expected to see sales go from virtually zero to a big number with a lot of zeroes is Ocugen (NASDAQ:OCGN). After the company reported $43,000 in sales last year, Wall Street's consensus has it generating $260 million in full-year sales by 2025. We're talking about a nearly 605,000% sales increase in five years.\nNot to sound like a broken record, but a COVID-19 vaccine is Ocugen's potential catalyst. The company has partnered with India's Bharat Biotech for the commercialization of Covaxin. A phase 3 trial of 25,800 adults aged 18 and up in India demonstrated a vaccine efficacy of 77.8% for symptomatic infections, 63.6% against asymptomatic infections, and most importantly was 93.4% effective against severe COVID-19 disease. The July-reported data from Bharat also showed a 65.2% efficacy against the delta variant.\nWith so many people left to be vaccinated, this probably sounds like a slam-dunk for some form of emergency authorization use in developed or emerging markets. However, there's a big problem for Ocugen: It only has co-commercialization rights for Covaxin in the U.S. and Canada. The U.S. has ordered more-than-enough vaccines to inoculate all eligible Americans, and likely has doses in reserve should booster shots become necessary. The same could be said for Canada, which invested heavily in vaccine purchases.\nWhile there's no such thing as having too many vaccine options during a pandemic, Covaxin's initial efficacy doesn't pop quite like the vaccines from Moderna, Pfizer/BioNTech, or even Novavax, which looks to be nearing its own emergency use authorization in the United States. Suffice it to say, Ocugen's sales forecast may prove unattainable.\nA rendering of the all-electric Nikola Tre semi. Image source: Nikola.\nNikola: 2,970,426% implied sales growth by 2025\nHowever, the crème de la crème of growth opportunities, at least pertaining to this list, is electric vehicle (EV) manufacturer Nikola (NASDAQ:NKLA). The expectation is that we'll see Nikola's sales catapult from a reported $95,000 in 2020 to a consensus of $2.822 billion by 2025. This equates to almost a 3 million percent jump in annual revenue.\nThe growth opportunity for EVs is pretty straightforward. With developed countries like the U.S. tackling climate change head-on, replacing fossil-fuel-burning vehicles with alternative-energy vehicles is one of the easiest ways to make a difference. It's going to take decades for consumers and businesses to make this shift, which leaves plenty of room for multiple EV manufacturers to thrive.\nThe issue for Nikola is that it's dealing with a public relations mess. Last year, short-side firm Hindenburg Research released a report that alleged Nikola was a fraud. Even though an independent review found that many of Hindenburg's allegations weren't true, it was discovered that founder Trevor Milton's statements regarding pre-sells weren't accurate.\nDespite stepping down last year, Milton was indicted by the U.S. Department of Justice on three charges of misleading investors. Ultimately, Nikola will have to overcome a breach of trust to sell its vehicles, and it likely will need a lot more cash than it has now to build up its production. Personally, I'm skeptical the company will reach this lofty sales consensus by mid-decade.","news_type":1},"isVote":1,"tweetType":1,"viewCount":267,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":862874228,"gmtCreate":1632873118714,"gmtModify":1632873118714,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Grt","listText":"Grt","text":"Grt","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/862874228","repostId":"1179744266","repostType":4,"repost":{"id":"1179744266","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1632859283,"share":"https://www.laohu8.com/m/news/1179744266?lang=&edition=full","pubTime":"2021-09-29 04:01","market":"us","language":"en","title":"Wall Street swoons on rising Treasury yields, growing inflation worries","url":"https://stock-news.laohu8.com/highlight/detail?id=1179744266","media":"Reuters","summary":"S&P 500's worst day since May, Nasdaq's worst since March\nFord rises on $11.4 bln investment with SK","content":"<ul>\n <li>S&amp;P 500's worst day since May, Nasdaq's worst since March</li>\n <li>Ford rises on $11.4 bln investment with SK Innovation</li>\n <li>Indexes drop: Dow 1.63%, S&amp;P 2.04%, Nasdaq 2.83% (Updates with closing prices)</li>\n</ul>\n<p>NEW YORK, Sept 28 (Reuters) - Wall Street stocks ended sharply lower on Tuesday in a broad sell-off driven by rising U.S. Treasury yields, deepening concerns over persistent inflation, and contentious debt ceiling negotiations in Washington.</p>\n<p>All three major U.S. stock indexes slid nearly 2% or more, with interest rate sensitive tech and tech-adjacent stocks weighing heaviest as investors lost their risk appetite.</p>\n<p>It was the S&amp;P 500 index's biggest one-day percentage drop since May, and the Nasdaq's largest since March.</p>\n<p>The S&amp;P 500 and the Nasdaq Composite index were on track for their largest monthly declines since September 2020.</p>\n<p>\"The big picture is the sudden surge in the past week of yields, which has led to a 'sell first, ask questions later' mentality,\" Ryan Detrick, senior market strategist at LPL Financial in Charlotte, North Carolina.</p>\n<p>\"(But) there are multiple factors weighing on sentiment today,\" Detrick added. \"The back-and-forth in Washington with the debt ceiling and the spending bill and potential higher taxes have weighed on overall investor psyche and has led to a pretty good sized sell-off.\"</p>\n<p>The benchmark index was also setting a course for its weakest quarterly performance since the COVID pandemic brought the global economy to its knees.</p>\n<p>Weakness pervaded across most asset classes, including gold, suggesting widespread risk-off sentiment.</p>\n<p>U.S. Treasury yields continued rising, with 10-year yields reaching their highest level since June, as inflation expectations heated up and fears grew that the U.S. Federal Reserve could shorten its timeline for tightening its monetary policy.</p>\n<p>Treasury Secretary Janet Yellen said she expected inflation to end 2021 near 4% and warned lawmakers their failure to avert a government shutdown as the nation moves closer to exhausting its borrowing capabilities could cause \"serious harm\" to the economy.</p>\n<p>Senate Republicans appeared set to strike down Democrats' efforts to extend the government's borrowing authority and avoid a potential U.S. credit default.</p>\n<p>A Conference Board report showed consumer confidence weakened unexpectedly in September to the lowest level since February.</p>\n<p>The Dow Jones Industrial Average fell 569.38 points, or 1.63%, to 34,299.99; the S&amp;P 500 lost 90.48 points, or 2.04%, at 4,352.63; and the Nasdaq Composite dropped 423.29 points, or 2.83%, to 14,546.68.</p>\n<p>Half of the S&amp;P 500's components closed 10% or more below their 52-week highs. That included 63 stocks that had fallen 20% or more.</p>\n<p>Among the 11 major sectors of the S&amp;P 500, all but energy ended red, with tech and communications services suffering the steepest percentage losses.</p>\n<p>Communications services shed 2.8%, the sector's biggest one-day percentage decline since January. The S&amp;P growth index closed at its lowest since July and posted its biggest one-day percentage drop since February.</p>\n<p>Microsoft Corp, Apple Inc, Amazon.com Inc and Alphabet Inc weighed heaviest on the S&amp;P and Nasdaq, falling between 2.4% and 3.6%.</p>\n<p>Ford Motor Co was one of the few bright spots, advancing 1.1% on news that it would join Korean battery partner SK Innovation to invest $11.4 billion to build an electric F-150 assembly plant and three U.S. battery plants.</p>\n<p>Declining issues outnumbered gainers on the NYSE by a 4.35-to-1 ratio; on Nasdaq, a 4.52-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 17 new 52-week highs and five new lows; the Nasdaq Composite recorded 54 new highs and 120 new lows.</p>\n<p>Volume on U.S. exchanges was 12.27 billion shares, compared with the 10.37 billion average over the last 20 trading days.</p>\n<p>(Reporting by Stephen Culp; Additional reporting by Noel Randewich and Sinead Carew in New York and Devik Jain in Bengaluru; Editing by Richard Chang)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street swoons on rising Treasury yields, growing inflation worries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street swoons on rising Treasury yields, growing inflation worries\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-29 04:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>S&amp;P 500's worst day since May, Nasdaq's worst since March</li>\n <li>Ford rises on $11.4 bln investment with SK Innovation</li>\n <li>Indexes drop: Dow 1.63%, S&amp;P 2.04%, Nasdaq 2.83% (Updates with closing prices)</li>\n</ul>\n<p>NEW YORK, Sept 28 (Reuters) - Wall Street stocks ended sharply lower on Tuesday in a broad sell-off driven by rising U.S. Treasury yields, deepening concerns over persistent inflation, and contentious debt ceiling negotiations in Washington.</p>\n<p>All three major U.S. stock indexes slid nearly 2% or more, with interest rate sensitive tech and tech-adjacent stocks weighing heaviest as investors lost their risk appetite.</p>\n<p>It was the S&amp;P 500 index's biggest one-day percentage drop since May, and the Nasdaq's largest since March.</p>\n<p>The S&amp;P 500 and the Nasdaq Composite index were on track for their largest monthly declines since September 2020.</p>\n<p>\"The big picture is the sudden surge in the past week of yields, which has led to a 'sell first, ask questions later' mentality,\" Ryan Detrick, senior market strategist at LPL Financial in Charlotte, North Carolina.</p>\n<p>\"(But) there are multiple factors weighing on sentiment today,\" Detrick added. \"The back-and-forth in Washington with the debt ceiling and the spending bill and potential higher taxes have weighed on overall investor psyche and has led to a pretty good sized sell-off.\"</p>\n<p>The benchmark index was also setting a course for its weakest quarterly performance since the COVID pandemic brought the global economy to its knees.</p>\n<p>Weakness pervaded across most asset classes, including gold, suggesting widespread risk-off sentiment.</p>\n<p>U.S. Treasury yields continued rising, with 10-year yields reaching their highest level since June, as inflation expectations heated up and fears grew that the U.S. Federal Reserve could shorten its timeline for tightening its monetary policy.</p>\n<p>Treasury Secretary Janet Yellen said she expected inflation to end 2021 near 4% and warned lawmakers their failure to avert a government shutdown as the nation moves closer to exhausting its borrowing capabilities could cause \"serious harm\" to the economy.</p>\n<p>Senate Republicans appeared set to strike down Democrats' efforts to extend the government's borrowing authority and avoid a potential U.S. credit default.</p>\n<p>A Conference Board report showed consumer confidence weakened unexpectedly in September to the lowest level since February.</p>\n<p>The Dow Jones Industrial Average fell 569.38 points, or 1.63%, to 34,299.99; the S&amp;P 500 lost 90.48 points, or 2.04%, at 4,352.63; and the Nasdaq Composite dropped 423.29 points, or 2.83%, to 14,546.68.</p>\n<p>Half of the S&amp;P 500's components closed 10% or more below their 52-week highs. That included 63 stocks that had fallen 20% or more.</p>\n<p>Among the 11 major sectors of the S&amp;P 500, all but energy ended red, with tech and communications services suffering the steepest percentage losses.</p>\n<p>Communications services shed 2.8%, the sector's biggest one-day percentage decline since January. The S&amp;P growth index closed at its lowest since July and posted its biggest one-day percentage drop since February.</p>\n<p>Microsoft Corp, Apple Inc, Amazon.com Inc and Alphabet Inc weighed heaviest on the S&amp;P and Nasdaq, falling between 2.4% and 3.6%.</p>\n<p>Ford Motor Co was one of the few bright spots, advancing 1.1% on news that it would join Korean battery partner SK Innovation to invest $11.4 billion to build an electric F-150 assembly plant and three U.S. battery plants.</p>\n<p>Declining issues outnumbered gainers on the NYSE by a 4.35-to-1 ratio; on Nasdaq, a 4.52-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 17 new 52-week highs and five new lows; the Nasdaq Composite recorded 54 new highs and 120 new lows.</p>\n<p>Volume on U.S. exchanges was 12.27 billion shares, compared with the 10.37 billion average over the last 20 trading days.</p>\n<p>(Reporting by Stephen Culp; Additional reporting by Noel Randewich and Sinead Carew in New York and Devik Jain in Bengaluru; Editing by Richard Chang)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯","SPY":"标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1179744266","content_text":"S&P 500's worst day since May, Nasdaq's worst since March\nFord rises on $11.4 bln investment with SK Innovation\nIndexes drop: Dow 1.63%, S&P 2.04%, Nasdaq 2.83% (Updates with closing prices)\n\nNEW YORK, Sept 28 (Reuters) - Wall Street stocks ended sharply lower on Tuesday in a broad sell-off driven by rising U.S. Treasury yields, deepening concerns over persistent inflation, and contentious debt ceiling negotiations in Washington.\nAll three major U.S. stock indexes slid nearly 2% or more, with interest rate sensitive tech and tech-adjacent stocks weighing heaviest as investors lost their risk appetite.\nIt was the S&P 500 index's biggest one-day percentage drop since May, and the Nasdaq's largest since March.\nThe S&P 500 and the Nasdaq Composite index were on track for their largest monthly declines since September 2020.\n\"The big picture is the sudden surge in the past week of yields, which has led to a 'sell first, ask questions later' mentality,\" Ryan Detrick, senior market strategist at LPL Financial in Charlotte, North Carolina.\n\"(But) there are multiple factors weighing on sentiment today,\" Detrick added. \"The back-and-forth in Washington with the debt ceiling and the spending bill and potential higher taxes have weighed on overall investor psyche and has led to a pretty good sized sell-off.\"\nThe benchmark index was also setting a course for its weakest quarterly performance since the COVID pandemic brought the global economy to its knees.\nWeakness pervaded across most asset classes, including gold, suggesting widespread risk-off sentiment.\nU.S. Treasury yields continued rising, with 10-year yields reaching their highest level since June, as inflation expectations heated up and fears grew that the U.S. Federal Reserve could shorten its timeline for tightening its monetary policy.\nTreasury Secretary Janet Yellen said she expected inflation to end 2021 near 4% and warned lawmakers their failure to avert a government shutdown as the nation moves closer to exhausting its borrowing capabilities could cause \"serious harm\" to the economy.\nSenate Republicans appeared set to strike down Democrats' efforts to extend the government's borrowing authority and avoid a potential U.S. credit default.\nA Conference Board report showed consumer confidence weakened unexpectedly in September to the lowest level since February.\nThe Dow Jones Industrial Average fell 569.38 points, or 1.63%, to 34,299.99; the S&P 500 lost 90.48 points, or 2.04%, at 4,352.63; and the Nasdaq Composite dropped 423.29 points, or 2.83%, to 14,546.68.\nHalf of the S&P 500's components closed 10% or more below their 52-week highs. That included 63 stocks that had fallen 20% or more.\nAmong the 11 major sectors of the S&P 500, all but energy ended red, with tech and communications services suffering the steepest percentage losses.\nCommunications services shed 2.8%, the sector's biggest one-day percentage decline since January. The S&P growth index closed at its lowest since July and posted its biggest one-day percentage drop since February.\nMicrosoft Corp, Apple Inc, Amazon.com Inc and Alphabet Inc weighed heaviest on the S&P and Nasdaq, falling between 2.4% and 3.6%.\nFord Motor Co was one of the few bright spots, advancing 1.1% on news that it would join Korean battery partner SK Innovation to invest $11.4 billion to build an electric F-150 assembly plant and three U.S. battery plants.\nDeclining issues outnumbered gainers on the NYSE by a 4.35-to-1 ratio; on Nasdaq, a 4.52-to-1 ratio favored decliners.\nThe S&P 500 posted 17 new 52-week highs and five new lows; the Nasdaq Composite recorded 54 new highs and 120 new lows.\nVolume on U.S. exchanges was 12.27 billion shares, compared with the 10.37 billion average over the last 20 trading days.\n(Reporting by Stephen Culp; Additional reporting by Noel Randewich and Sinead Carew in New York and Devik Jain in Bengaluru; Editing by Richard Chang)","news_type":1},"isVote":1,"tweetType":1,"viewCount":262,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866223170,"gmtCreate":1632786117990,"gmtModify":1632797597025,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/866223170","repostId":"2170995644","repostType":4,"isVote":1,"tweetType":1,"viewCount":262,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866229482,"gmtCreate":1632786107146,"gmtModify":1632797597112,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Grt","listText":"Grt","text":"Grt","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/866229482","repostId":"1112832451","repostType":4,"repost":{"id":"1112832451","pubTimestamp":1632756701,"share":"https://www.laohu8.com/m/news/1112832451?lang=&edition=full","pubTime":"2021-09-27 23:31","market":"us","language":"en","title":"Amazon Stock Falls. Morgan Stanley Cuts Its Price Target.","url":"https://stock-news.laohu8.com/highlight/detail?id=1112832451","media":"Barrons","summary":"Shares of Amazon.com were lower Monday after analysts at Morgan Stanley cut their price target, sayi","content":"<p>Shares of Amazon.com were lower Monday after analysts at Morgan Stanley cut their price target, saying a&nbsp;push by the online retailer and tech giant to add to its logistics workforce was adding to profit pressures.</p>\n<p>Amazon (ticker: AMZN) fell 1.97% to $3,358.04. Higher bond yields also were hitting the stock Monday, as they were other fast-growing tech shares. The Nasdaq was falling 0.38%.</p>\n<p></p>\n<p>Morgan Stanley analysts cut their price target $4,100&nbsp;from $4,300. They maintained their Overweight rating on the stock.</p>\n<p>Analysts surveyed by FactSet also rate the stock at Overweight but with a higher average target price of $4,153.</p>\n<p>“We have written in the past to how AMZN’s growing logisticsworkforce is set to enable more e-commerce share gains, faster ship speeds (1-day and same-day) and new business opportunities (like third party logistics) … but the cost of labor is rising,” wrote the analysts, led by Brian Nowak.</p>\n<p>The analyst lowered his 2021 and 2002 EBIT estimates on Amazon by 16% and 19%, respectively.</p>\n<p>Amazon announced in mid-September that it was hiring more than 125,000 drivers and warehouse workers and will pay them a starting average wage of more than $18 an hour —and up to $22.50 in some places.</p>\n<p></p>\n<p>The company has been on a hiring spree. At the beginning of September, the company announced it will fill 40,000 corporate and technology jobs; since the pandemic began in March 2020, Amazon has hired&nbsp;more than 450,000 people in the&nbsp;U.S.</p>\n<p>“Near-term estimates are heading lower … but in our view it is also important to remember that rising wages are impacting all businesses (most recently&nbsp;FedEx&nbsp;(FDX) last week) and AMZN competitors,” the analysts said.</p>\n<p><i>Barron’s</i> reported last week how labor-cost inflation looked to be biting into profit margins at shipping giant&nbsp;FedEx.</p>\n<p></p>\n<p>“We acknowledge profit misses and slowing revenue may hold back AMZN’s ability to outperform through this investment cycle,” wrote Morgan Stanley. “In our view, AMZN may be tactically range bound until retail revenue can re-accelerate and beat expectations” in the first half of 2022. </p>\n<p></p>\n<p></p>\n<p></p>\n<p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amazon Stock Falls. Morgan Stanley Cuts Its Price Target.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmazon Stock Falls. Morgan Stanley Cuts Its Price Target.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-27 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/amazon-amzn-stock-price-target-cut-51632755695?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Amazon.com were lower Monday after analysts at Morgan Stanley cut their price target, saying a push by the online retailer and tech giant to add to its logistics workforce was adding to ...</p>\n\n<a href=\"https://www.barrons.com/articles/amazon-amzn-stock-price-target-cut-51632755695?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊"},"source_url":"https://www.barrons.com/articles/amazon-amzn-stock-price-target-cut-51632755695?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1112832451","content_text":"Shares of Amazon.com were lower Monday after analysts at Morgan Stanley cut their price target, saying a push by the online retailer and tech giant to add to its logistics workforce was adding to profit pressures.\nAmazon (ticker: AMZN) fell 1.97% to $3,358.04. Higher bond yields also were hitting the stock Monday, as they were other fast-growing tech shares. The Nasdaq was falling 0.38%.\n\nMorgan Stanley analysts cut their price target $4,100 from $4,300. They maintained their Overweight rating on the stock.\nAnalysts surveyed by FactSet also rate the stock at Overweight but with a higher average target price of $4,153.\n“We have written in the past to how AMZN’s growing logisticsworkforce is set to enable more e-commerce share gains, faster ship speeds (1-day and same-day) and new business opportunities (like third party logistics) … but the cost of labor is rising,” wrote the analysts, led by Brian Nowak.\nThe analyst lowered his 2021 and 2002 EBIT estimates on Amazon by 16% and 19%, respectively.\nAmazon announced in mid-September that it was hiring more than 125,000 drivers and warehouse workers and will pay them a starting average wage of more than $18 an hour —and up to $22.50 in some places.\n\nThe company has been on a hiring spree. At the beginning of September, the company announced it will fill 40,000 corporate and technology jobs; since the pandemic began in March 2020, Amazon has hired more than 450,000 people in the U.S.\n“Near-term estimates are heading lower … but in our view it is also important to remember that rising wages are impacting all businesses (most recently FedEx (FDX) last week) and AMZN competitors,” the analysts said.\nBarron’s reported last week how labor-cost inflation looked to be biting into profit margins at shipping giant FedEx.\n\n“We acknowledge profit misses and slowing revenue may hold back AMZN’s ability to outperform through this investment cycle,” wrote Morgan Stanley. “In our view, AMZN may be tactically range bound until retail revenue can re-accelerate and beat expectations” in the first half of 2022.","news_type":1},"isVote":1,"tweetType":1,"viewCount":341,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866229999,"gmtCreate":1632786076611,"gmtModify":1632797597242,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Interesting","listText":"Interesting","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/866229999","repostId":"2170292226","repostType":4,"isVote":1,"tweetType":1,"viewCount":299,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866220463,"gmtCreate":1632786060252,"gmtModify":1632797597286,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/866220463","repostId":"2170622225","repostType":4,"isVote":1,"tweetType":1,"viewCount":263,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866220278,"gmtCreate":1632786033494,"gmtModify":1632797597329,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice info","listText":"Nice info","text":"Nice info","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/866220278","repostId":"2170622704","repostType":4,"repost":{"id":"2170622704","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1632779133,"share":"https://www.laohu8.com/m/news/2170622704?lang=&edition=full","pubTime":"2021-09-28 05:45","market":"us","language":"en","title":"Merck in advanced talks to buy Acceleron Pharma - WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2170622704","media":"Reuters","summary":"Sept 27 (Reuters) - Merck & Co is in advanced talks to acquire drugmaker Acceleron Pharma Inc , the ","content":"<p>Sept 27 (Reuters) - <a href=\"https://laohu8.com/S/MRK\">Merck</a> &amp; Co&nbsp;is in advanced talks to acquire drugmaker <a href=\"https://laohu8.com/S/XLRN\">Acceleron Pharma</a> Inc , the Wall Street Journal reported&nbsp;on Monday, citing people familiar with the matter.</p>\n<p>A Bloomberg report last week said Acceleron was in talks to be acquired for more than $11 billion.</p>\n<p>(Reporting by Uday Sampath in Bengaluru; Editing by Shinjini Ganguli)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck in advanced talks to buy Acceleron Pharma - WSJ</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck in advanced talks to buy Acceleron Pharma - WSJ\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-28 05:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sept 27 (Reuters) - <a href=\"https://laohu8.com/S/MRK\">Merck</a> &amp; Co&nbsp;is in advanced talks to acquire drugmaker <a href=\"https://laohu8.com/S/XLRN\">Acceleron Pharma</a> Inc , the Wall Street Journal reported&nbsp;on Monday, citing people familiar with the matter.</p>\n<p>A Bloomberg report last week said Acceleron was in talks to be acquired for more than $11 billion.</p>\n<p>(Reporting by Uday Sampath in Bengaluru; Editing by Shinjini Ganguli)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东","XLRN":"Acceleron Pharma Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2170622704","content_text":"Sept 27 (Reuters) - Merck & Co is in advanced talks to acquire drugmaker Acceleron Pharma Inc , the Wall Street Journal reported on Monday, citing people familiar with the matter.\nA Bloomberg report last week said Acceleron was in talks to be acquired for more than $11 billion.\n(Reporting by Uday Sampath in Bengaluru; Editing by Shinjini Ganguli)","news_type":1},"isVote":1,"tweetType":1,"viewCount":334,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":607780455,"gmtCreate":1639592640979,"gmtModify":1639592641074,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607780455","repostId":"1124789927","repostType":4,"isVote":1,"tweetType":1,"viewCount":850,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876320323,"gmtCreate":1637274526267,"gmtModify":1637274526267,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876320323","repostId":"1130402483","repostType":4,"isVote":1,"tweetType":1,"viewCount":587,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":862874228,"gmtCreate":1632873118714,"gmtModify":1632873118714,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Grt","listText":"Grt","text":"Grt","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/862874228","repostId":"1179744266","repostType":4,"repost":{"id":"1179744266","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1632859283,"share":"https://www.laohu8.com/m/news/1179744266?lang=&edition=full","pubTime":"2021-09-29 04:01","market":"us","language":"en","title":"Wall Street swoons on rising Treasury yields, growing inflation worries","url":"https://stock-news.laohu8.com/highlight/detail?id=1179744266","media":"Reuters","summary":"S&P 500's worst day since May, Nasdaq's worst since March\nFord rises on $11.4 bln investment with SK","content":"<ul>\n <li>S&amp;P 500's worst day since May, Nasdaq's worst since March</li>\n <li>Ford rises on $11.4 bln investment with SK Innovation</li>\n <li>Indexes drop: Dow 1.63%, S&amp;P 2.04%, Nasdaq 2.83% (Updates with closing prices)</li>\n</ul>\n<p>NEW YORK, Sept 28 (Reuters) - Wall Street stocks ended sharply lower on Tuesday in a broad sell-off driven by rising U.S. Treasury yields, deepening concerns over persistent inflation, and contentious debt ceiling negotiations in Washington.</p>\n<p>All three major U.S. stock indexes slid nearly 2% or more, with interest rate sensitive tech and tech-adjacent stocks weighing heaviest as investors lost their risk appetite.</p>\n<p>It was the S&amp;P 500 index's biggest one-day percentage drop since May, and the Nasdaq's largest since March.</p>\n<p>The S&amp;P 500 and the Nasdaq Composite index were on track for their largest monthly declines since September 2020.</p>\n<p>\"The big picture is the sudden surge in the past week of yields, which has led to a 'sell first, ask questions later' mentality,\" Ryan Detrick, senior market strategist at LPL Financial in Charlotte, North Carolina.</p>\n<p>\"(But) there are multiple factors weighing on sentiment today,\" Detrick added. \"The back-and-forth in Washington with the debt ceiling and the spending bill and potential higher taxes have weighed on overall investor psyche and has led to a pretty good sized sell-off.\"</p>\n<p>The benchmark index was also setting a course for its weakest quarterly performance since the COVID pandemic brought the global economy to its knees.</p>\n<p>Weakness pervaded across most asset classes, including gold, suggesting widespread risk-off sentiment.</p>\n<p>U.S. Treasury yields continued rising, with 10-year yields reaching their highest level since June, as inflation expectations heated up and fears grew that the U.S. Federal Reserve could shorten its timeline for tightening its monetary policy.</p>\n<p>Treasury Secretary Janet Yellen said she expected inflation to end 2021 near 4% and warned lawmakers their failure to avert a government shutdown as the nation moves closer to exhausting its borrowing capabilities could cause \"serious harm\" to the economy.</p>\n<p>Senate Republicans appeared set to strike down Democrats' efforts to extend the government's borrowing authority and avoid a potential U.S. credit default.</p>\n<p>A Conference Board report showed consumer confidence weakened unexpectedly in September to the lowest level since February.</p>\n<p>The Dow Jones Industrial Average fell 569.38 points, or 1.63%, to 34,299.99; the S&amp;P 500 lost 90.48 points, or 2.04%, at 4,352.63; and the Nasdaq Composite dropped 423.29 points, or 2.83%, to 14,546.68.</p>\n<p>Half of the S&amp;P 500's components closed 10% or more below their 52-week highs. That included 63 stocks that had fallen 20% or more.</p>\n<p>Among the 11 major sectors of the S&amp;P 500, all but energy ended red, with tech and communications services suffering the steepest percentage losses.</p>\n<p>Communications services shed 2.8%, the sector's biggest one-day percentage decline since January. The S&amp;P growth index closed at its lowest since July and posted its biggest one-day percentage drop since February.</p>\n<p>Microsoft Corp, Apple Inc, Amazon.com Inc and Alphabet Inc weighed heaviest on the S&amp;P and Nasdaq, falling between 2.4% and 3.6%.</p>\n<p>Ford Motor Co was one of the few bright spots, advancing 1.1% on news that it would join Korean battery partner SK Innovation to invest $11.4 billion to build an electric F-150 assembly plant and three U.S. battery plants.</p>\n<p>Declining issues outnumbered gainers on the NYSE by a 4.35-to-1 ratio; on Nasdaq, a 4.52-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 17 new 52-week highs and five new lows; the Nasdaq Composite recorded 54 new highs and 120 new lows.</p>\n<p>Volume on U.S. exchanges was 12.27 billion shares, compared with the 10.37 billion average over the last 20 trading days.</p>\n<p>(Reporting by Stephen Culp; Additional reporting by Noel Randewich and Sinead Carew in New York and Devik Jain in Bengaluru; Editing by Richard Chang)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street swoons on rising Treasury yields, growing inflation worries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street swoons on rising Treasury yields, growing inflation worries\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-29 04:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>S&amp;P 500's worst day since May, Nasdaq's worst since March</li>\n <li>Ford rises on $11.4 bln investment with SK Innovation</li>\n <li>Indexes drop: Dow 1.63%, S&amp;P 2.04%, Nasdaq 2.83% (Updates with closing prices)</li>\n</ul>\n<p>NEW YORK, Sept 28 (Reuters) - Wall Street stocks ended sharply lower on Tuesday in a broad sell-off driven by rising U.S. Treasury yields, deepening concerns over persistent inflation, and contentious debt ceiling negotiations in Washington.</p>\n<p>All three major U.S. stock indexes slid nearly 2% or more, with interest rate sensitive tech and tech-adjacent stocks weighing heaviest as investors lost their risk appetite.</p>\n<p>It was the S&amp;P 500 index's biggest one-day percentage drop since May, and the Nasdaq's largest since March.</p>\n<p>The S&amp;P 500 and the Nasdaq Composite index were on track for their largest monthly declines since September 2020.</p>\n<p>\"The big picture is the sudden surge in the past week of yields, which has led to a 'sell first, ask questions later' mentality,\" Ryan Detrick, senior market strategist at LPL Financial in Charlotte, North Carolina.</p>\n<p>\"(But) there are multiple factors weighing on sentiment today,\" Detrick added. \"The back-and-forth in Washington with the debt ceiling and the spending bill and potential higher taxes have weighed on overall investor psyche and has led to a pretty good sized sell-off.\"</p>\n<p>The benchmark index was also setting a course for its weakest quarterly performance since the COVID pandemic brought the global economy to its knees.</p>\n<p>Weakness pervaded across most asset classes, including gold, suggesting widespread risk-off sentiment.</p>\n<p>U.S. Treasury yields continued rising, with 10-year yields reaching their highest level since June, as inflation expectations heated up and fears grew that the U.S. Federal Reserve could shorten its timeline for tightening its monetary policy.</p>\n<p>Treasury Secretary Janet Yellen said she expected inflation to end 2021 near 4% and warned lawmakers their failure to avert a government shutdown as the nation moves closer to exhausting its borrowing capabilities could cause \"serious harm\" to the economy.</p>\n<p>Senate Republicans appeared set to strike down Democrats' efforts to extend the government's borrowing authority and avoid a potential U.S. credit default.</p>\n<p>A Conference Board report showed consumer confidence weakened unexpectedly in September to the lowest level since February.</p>\n<p>The Dow Jones Industrial Average fell 569.38 points, or 1.63%, to 34,299.99; the S&amp;P 500 lost 90.48 points, or 2.04%, at 4,352.63; and the Nasdaq Composite dropped 423.29 points, or 2.83%, to 14,546.68.</p>\n<p>Half of the S&amp;P 500's components closed 10% or more below their 52-week highs. That included 63 stocks that had fallen 20% or more.</p>\n<p>Among the 11 major sectors of the S&amp;P 500, all but energy ended red, with tech and communications services suffering the steepest percentage losses.</p>\n<p>Communications services shed 2.8%, the sector's biggest one-day percentage decline since January. The S&amp;P growth index closed at its lowest since July and posted its biggest one-day percentage drop since February.</p>\n<p>Microsoft Corp, Apple Inc, Amazon.com Inc and Alphabet Inc weighed heaviest on the S&amp;P and Nasdaq, falling between 2.4% and 3.6%.</p>\n<p>Ford Motor Co was one of the few bright spots, advancing 1.1% on news that it would join Korean battery partner SK Innovation to invest $11.4 billion to build an electric F-150 assembly plant and three U.S. battery plants.</p>\n<p>Declining issues outnumbered gainers on the NYSE by a 4.35-to-1 ratio; on Nasdaq, a 4.52-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 17 new 52-week highs and five new lows; the Nasdaq Composite recorded 54 new highs and 120 new lows.</p>\n<p>Volume on U.S. exchanges was 12.27 billion shares, compared with the 10.37 billion average over the last 20 trading days.</p>\n<p>(Reporting by Stephen Culp; Additional reporting by Noel Randewich and Sinead Carew in New York and Devik Jain in Bengaluru; Editing by Richard Chang)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯","SPY":"标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1179744266","content_text":"S&P 500's worst day since May, Nasdaq's worst since March\nFord rises on $11.4 bln investment with SK Innovation\nIndexes drop: Dow 1.63%, S&P 2.04%, Nasdaq 2.83% (Updates with closing prices)\n\nNEW YORK, Sept 28 (Reuters) - Wall Street stocks ended sharply lower on Tuesday in a broad sell-off driven by rising U.S. Treasury yields, deepening concerns over persistent inflation, and contentious debt ceiling negotiations in Washington.\nAll three major U.S. stock indexes slid nearly 2% or more, with interest rate sensitive tech and tech-adjacent stocks weighing heaviest as investors lost their risk appetite.\nIt was the S&P 500 index's biggest one-day percentage drop since May, and the Nasdaq's largest since March.\nThe S&P 500 and the Nasdaq Composite index were on track for their largest monthly declines since September 2020.\n\"The big picture is the sudden surge in the past week of yields, which has led to a 'sell first, ask questions later' mentality,\" Ryan Detrick, senior market strategist at LPL Financial in Charlotte, North Carolina.\n\"(But) there are multiple factors weighing on sentiment today,\" Detrick added. \"The back-and-forth in Washington with the debt ceiling and the spending bill and potential higher taxes have weighed on overall investor psyche and has led to a pretty good sized sell-off.\"\nThe benchmark index was also setting a course for its weakest quarterly performance since the COVID pandemic brought the global economy to its knees.\nWeakness pervaded across most asset classes, including gold, suggesting widespread risk-off sentiment.\nU.S. Treasury yields continued rising, with 10-year yields reaching their highest level since June, as inflation expectations heated up and fears grew that the U.S. Federal Reserve could shorten its timeline for tightening its monetary policy.\nTreasury Secretary Janet Yellen said she expected inflation to end 2021 near 4% and warned lawmakers their failure to avert a government shutdown as the nation moves closer to exhausting its borrowing capabilities could cause \"serious harm\" to the economy.\nSenate Republicans appeared set to strike down Democrats' efforts to extend the government's borrowing authority and avoid a potential U.S. credit default.\nA Conference Board report showed consumer confidence weakened unexpectedly in September to the lowest level since February.\nThe Dow Jones Industrial Average fell 569.38 points, or 1.63%, to 34,299.99; the S&P 500 lost 90.48 points, or 2.04%, at 4,352.63; and the Nasdaq Composite dropped 423.29 points, or 2.83%, to 14,546.68.\nHalf of the S&P 500's components closed 10% or more below their 52-week highs. That included 63 stocks that had fallen 20% or more.\nAmong the 11 major sectors of the S&P 500, all but energy ended red, with tech and communications services suffering the steepest percentage losses.\nCommunications services shed 2.8%, the sector's biggest one-day percentage decline since January. The S&P growth index closed at its lowest since July and posted its biggest one-day percentage drop since February.\nMicrosoft Corp, Apple Inc, Amazon.com Inc and Alphabet Inc weighed heaviest on the S&P and Nasdaq, falling between 2.4% and 3.6%.\nFord Motor Co was one of the few bright spots, advancing 1.1% on news that it would join Korean battery partner SK Innovation to invest $11.4 billion to build an electric F-150 assembly plant and three U.S. battery plants.\nDeclining issues outnumbered gainers on the NYSE by a 4.35-to-1 ratio; on Nasdaq, a 4.52-to-1 ratio favored decliners.\nThe S&P 500 posted 17 new 52-week highs and five new lows; the Nasdaq Composite recorded 54 new highs and 120 new lows.\nVolume on U.S. exchanges was 12.27 billion shares, compared with the 10.37 billion average over the last 20 trading days.\n(Reporting by Stephen Culp; Additional reporting by Noel Randewich and Sinead Carew in New York and Devik Jain in Bengaluru; Editing by Richard Chang)","news_type":1},"isVote":1,"tweetType":1,"viewCount":262,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":861052625,"gmtCreate":1632444550667,"gmtModify":1632724507735,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/861052625","repostId":"2169699539","repostType":4,"repost":{"id":"2169699539","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1632443306,"share":"https://www.laohu8.com/m/news/2169699539?lang=&edition=full","pubTime":"2021-09-24 08:28","market":"us","language":"en","title":"Results From Novavax Nanoflu Influenza Vaccine Phase 3 Clinical Trial Published In Lancet Infectious Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2169699539","media":"Reuters","summary":"Novavax Inc:Results From Novavax Nanoflu Influenza Vaccine Phase 3 Clinical Trial Published In Lance","content":"<p>Novavax Inc:Results From Novavax Nanoflu Influenza Vaccine Phase 3 Clinical Trial Published In Lancet Infectious Diseases.Novavax - Results From Nanoflu Influenza Vaccine Phase 3 Clinical Trial Achieved All Primary Endpoints.Novavax Inc - Nanoflu Vaccine Candidate Induced Significantly Enhanced Cell-Mediated Immune Responses.Novavax Inc - Nanoflu Was Well-Tolerated With A Comparable Safety Profile.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Results From Novavax Nanoflu Influenza Vaccine Phase 3 Clinical Trial Published In Lancet Infectious Diseases</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nResults From Novavax Nanoflu Influenza Vaccine Phase 3 Clinical Trial Published In Lancet Infectious Diseases\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-24 08:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax Inc:Results From Novavax Nanoflu Influenza Vaccine Phase 3 Clinical Trial Published In Lancet Infectious Diseases.Novavax - Results From Nanoflu Influenza Vaccine Phase 3 Clinical Trial Achieved All Primary Endpoints.Novavax Inc - Nanoflu Vaccine Candidate Induced Significantly Enhanced Cell-Mediated Immune Responses.Novavax Inc - Nanoflu Was Well-Tolerated With A Comparable Safety Profile.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169699539","content_text":"Novavax Inc:Results From Novavax Nanoflu Influenza Vaccine Phase 3 Clinical Trial Published In Lancet Infectious Diseases.Novavax - Results From Nanoflu Influenza Vaccine Phase 3 Clinical Trial Achieved All Primary Endpoints.Novavax Inc - Nanoflu Vaccine Candidate Induced Significantly Enhanced Cell-Mediated Immune Responses.Novavax Inc - Nanoflu Was Well-Tolerated With A Comparable Safety Profile.","news_type":1},"isVote":1,"tweetType":1,"viewCount":84,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":822910326,"gmtCreate":1634084132917,"gmtModify":1634084133026,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Grt","listText":"Grt","text":"Grt","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/822910326","repostId":"2175137885","repostType":4,"isVote":1,"tweetType":1,"viewCount":663,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":828933068,"gmtCreate":1633831081657,"gmtModify":1633831081657,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good info","listText":"Good info","text":"Good info","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/828933068","repostId":"1111746159","repostType":4,"isVote":1,"tweetType":1,"viewCount":702,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866220056,"gmtCreate":1632785987075,"gmtModify":1632797597460,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/866220056","repostId":"2170627368","repostType":4,"repost":{"id":"2170627368","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1632780251,"share":"https://www.laohu8.com/m/news/2170627368?lang=&edition=full","pubTime":"2021-09-28 06:04","market":"us","language":"en","title":"Alternative asset manager P10 files for U.S. IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2170627368","media":"Reuters","summary":"Sept 27 (Reuters) - P10 Inc, the holding company of investment firm P10 Holdings Inc, on Monday file","content":"<p>Sept 27 (Reuters) - P10 Inc, the holding company of investment firm P10 Holdings Inc, on Monday filed for an IPO in the United States, becoming the latest alternative asset manager exploring a public listing as shares of such firms have rallied this year.</p>\n<p>While P10 has not yet set terms for its IPO, Reuters reported earlier this month the Dallas-based firm could seek a valuation of more than $1 billion.</p>\n<p>Private equity giant TPG and L Catterton are also reportedly exploring public listings, as shares of major buyout firms have soared this year.</p>\n<p>Blackstone Inc's shares are up 90%, while KKR &amp; Co Inc's shares have gained nearly 52% this year, with low interest rates and a surge in corporate valuations boosting their financing ability and value of their holdings.</p>\n<p>P10 focuses on lower-middle market deals in areas such as private equity, venture capital and private credit, and operates four divisions that include RCP Advisors and TrueBridge Capital Partners.</p>\n<p>The company, which will list on the New York Stock Exchange, had $14.2 billion of fee-paying assets under management as of June 30, it said in its filing.</p>\n<p>For the six months ended June 30, P10's revenue was $66.8 million, more than doubling from the same period last year. Net income attributable to the company rose 41% to $4.2 million.</p>\n<p><a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a>, J.P. Morgan, Barclays and UBS Investment Bank are among the underwriters for the IPO.</p>\n<p>(Reporting by Niket Nishant in Bengaluru; Editing by Shounak Dasgupta)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alternative asset manager P10 files for U.S. IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlternative asset manager P10 files for U.S. IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-28 06:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sept 27 (Reuters) - P10 Inc, the holding company of investment firm P10 Holdings Inc, on Monday filed for an IPO in the United States, becoming the latest alternative asset manager exploring a public listing as shares of such firms have rallied this year.</p>\n<p>While P10 has not yet set terms for its IPO, Reuters reported earlier this month the Dallas-based firm could seek a valuation of more than $1 billion.</p>\n<p>Private equity giant TPG and L Catterton are also reportedly exploring public listings, as shares of major buyout firms have soared this year.</p>\n<p>Blackstone Inc's shares are up 90%, while KKR &amp; Co Inc's shares have gained nearly 52% this year, with low interest rates and a surge in corporate valuations boosting their financing ability and value of their holdings.</p>\n<p>P10 focuses on lower-middle market deals in areas such as private equity, venture capital and private credit, and operates four divisions that include RCP Advisors and TrueBridge Capital Partners.</p>\n<p>The company, which will list on the New York Stock Exchange, had $14.2 billion of fee-paying assets under management as of June 30, it said in its filing.</p>\n<p>For the six months ended June 30, P10's revenue was $66.8 million, more than doubling from the same period last year. Net income attributable to the company rose 41% to $4.2 million.</p>\n<p><a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a>, J.P. Morgan, Barclays and UBS Investment Bank are among the underwriters for the IPO.</p>\n<p>(Reporting by Niket Nishant in Bengaluru; Editing by Shounak Dasgupta)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2170627368","content_text":"Sept 27 (Reuters) - P10 Inc, the holding company of investment firm P10 Holdings Inc, on Monday filed for an IPO in the United States, becoming the latest alternative asset manager exploring a public listing as shares of such firms have rallied this year.\nWhile P10 has not yet set terms for its IPO, Reuters reported earlier this month the Dallas-based firm could seek a valuation of more than $1 billion.\nPrivate equity giant TPG and L Catterton are also reportedly exploring public listings, as shares of major buyout firms have soared this year.\nBlackstone Inc's shares are up 90%, while KKR & Co Inc's shares have gained nearly 52% this year, with low interest rates and a surge in corporate valuations boosting their financing ability and value of their holdings.\nP10 focuses on lower-middle market deals in areas such as private equity, venture capital and private credit, and operates four divisions that include RCP Advisors and TrueBridge Capital Partners.\nThe company, which will list on the New York Stock Exchange, had $14.2 billion of fee-paying assets under management as of June 30, it said in its filing.\nFor the six months ended June 30, P10's revenue was $66.8 million, more than doubling from the same period last year. Net income attributable to the company rose 41% to $4.2 million.\nMorgan Stanley, J.P. Morgan, Barclays and UBS Investment Bank are among the underwriters for the IPO.\n(Reporting by Niket Nishant in Bengaluru; Editing by Shounak Dasgupta)","news_type":1},"isVote":1,"tweetType":1,"viewCount":42,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605685662,"gmtCreate":1639152437752,"gmtModify":1639152437813,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"[Happy]&nbsp;","listText":"[Happy]&nbsp;","text":"[Happy]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605685662","repostId":"1148141788","repostType":4,"isVote":1,"tweetType":1,"viewCount":411,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":824043682,"gmtCreate":1634264655689,"gmtModify":1634274404389,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/824043682","repostId":"1182032876","repostType":4,"isVote":1,"tweetType":1,"viewCount":590,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693672096,"gmtCreate":1640019767125,"gmtModify":1640019767190,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Grt","listText":"Grt","text":"Grt","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693672096","repostId":"2192804351","repostType":4,"repost":{"id":"2192804351","pubTimestamp":1640013682,"share":"https://www.laohu8.com/m/news/2192804351?lang=&edition=full","pubTime":"2021-12-20 23:21","market":"us","language":"en","title":"Oracle to buy Cerner for $28 bln in healthcare sector push","url":"https://stock-news.laohu8.com/highlight/detail?id=2192804351","media":"Reuters","summary":"Dec 20 (Reuters) - Enterprise software maker Oracle Corp said on Monday it would buy electronic medi","content":"<p>Dec 20 (Reuters) - Enterprise software maker Oracle Corp said on Monday it would buy electronic medical records company Cerner Corp for $28.3 billion, in a bid to strengthen its presence in the healthcare sector.</p>\n<p>Cerner shareholders will receive $95 in cash for each share they hold, representing a premium of 5.8% to the company's closing price on Friday.</p>\n<p>The deal, which will be Oracle's biggest ever after its acquisition of PeopleSoft in 2004, will help the software maker bolster the services its provides to healthcare clients, including insurers.</p>\n<p>Cerner, the biggest seller of software used for electronic recording of healthcare data in the United States after Epic Systems Corp, will give Oracle access to data it can use to train and improve its artificial intelligence-based cloud services.</p>\n<p>Since the pandemic began, demand for cloud-based solutions in the healthcare sector has picked up pace, including telehealth services as well as automation of health records.</p>\n<p>The deal is expected to close in 2022, the company said. (Reporting by Chavi Mehta and Tiyashi Datta in Bengaluru; Editing by Krishna Chandra Eluri)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oracle to buy Cerner for $28 bln in healthcare sector push</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOracle to buy Cerner for $28 bln in healthcare sector push\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-20 23:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-oracle-buy-cerner-28-144822643.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dec 20 (Reuters) - Enterprise software maker Oracle Corp said on Monday it would buy electronic medical records company Cerner Corp for $28.3 billion, in a bid to strengthen its presence in the ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-oracle-buy-cerner-28-144822643.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CERN":"美国塞纳","ORCL":"甲骨文","BK4167":"医疗保健技术"},"source_url":"https://finance.yahoo.com/news/1-oracle-buy-cerner-28-144822643.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2192804351","content_text":"Dec 20 (Reuters) - Enterprise software maker Oracle Corp said on Monday it would buy electronic medical records company Cerner Corp for $28.3 billion, in a bid to strengthen its presence in the healthcare sector.\nCerner shareholders will receive $95 in cash for each share they hold, representing a premium of 5.8% to the company's closing price on Friday.\nThe deal, which will be Oracle's biggest ever after its acquisition of PeopleSoft in 2004, will help the software maker bolster the services its provides to healthcare clients, including insurers.\nCerner, the biggest seller of software used for electronic recording of healthcare data in the United States after Epic Systems Corp, will give Oracle access to data it can use to train and improve its artificial intelligence-based cloud services.\nSince the pandemic began, demand for cloud-based solutions in the healthcare sector has picked up pace, including telehealth services as well as automation of health records.\nThe deal is expected to close in 2022, the company said. (Reporting by Chavi Mehta and Tiyashi Datta in Bengaluru; Editing by Krishna Chandra Eluri)","news_type":1},"isVote":1,"tweetType":1,"viewCount":403,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":867787148,"gmtCreate":1633314819339,"gmtModify":1633314819405,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/867787148","repostId":"1114921615","repostType":4,"isVote":1,"tweetType":1,"viewCount":269,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865409165,"gmtCreate":1633008480605,"gmtModify":1633008480687,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good info","listText":"Good info","text":"Good info","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865409165","repostId":"1130437913","repostType":4,"repost":{"id":"1130437913","pubTimestamp":1633001521,"share":"https://www.laohu8.com/m/news/1130437913?lang=&edition=full","pubTime":"2021-09-30 19:32","market":"us","language":"en","title":"Chamath Palihapitiya Exits Tesla Stock. Here’s Why.","url":"https://stock-news.laohu8.com/highlight/detail?id=1130437913","media":"Barrons","summary":"High-profile investor Chamath Palihapitiya said Wednesday that he sold his position in Tesla stock o","content":"<p>High-profile investor Chamath Palihapitiya said Wednesday that he sold his position in Tesla stock over the last year.</p>\n<p>The founder of venture firm Social Capital has been bullish on Tesla (ticker: TSLA) in the past, telling CNBC in January—when the shares were trading hands above $800—that the stock could double or triple in price.</p>\n<p></p>\n<p>But the former Facebook executive, and special-purpose acquisition company (SPAC) investor who helped launch&nbsp;Virgin Galactic‘s (SPCE) listing, said he cashed out of Tesla to fund other projects “in the last year or so.”</p>\n<p>Speaking at a CNBC conference Wednesday, Palihapitiya said he no longer had a sizable stock position in Tesla, having sold down his stake while the stock was on a tear.</p>\n<p>“The price has allowed me to,” Palihapitiya said. “I don’t have an infinite pool of capital.”</p>\n<p>“When I have these ideas, the money has to come from someplace,” the investor said, speaking of a new venture linked to distributed energy utilities.</p>\n<p>Tesla stock rose nearly 700% in 2020, from less than $90 a share, to more than $700. It traded near $900 in early 2021, and today hovers around $780, having risen 7% year-to-date, lagging the&nbsp;S&amp;P 500’s&nbsp;16% and the&nbsp;Dow Jones Industrial Average’s&nbsp;12%.</p>\n<p>Palihapitiya isn’t the only Tesla booster who has been selling shares of the company. ARK Invest’s Cathie Wood sold more than $200 million of Tesla stock recently. Unlike Palihapitiya, it remains the largest holding in her&nbsp;ARK Innovation ETF&nbsp;(ARKK).</p>\n<p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chamath Palihapitiya Exits Tesla Stock. Here’s Why.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChamath Palihapitiya Exits Tesla Stock. Here’s Why.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-30 19:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/tesla-stock-sold-chamath-palihapitiya-51632997123?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>High-profile investor Chamath Palihapitiya said Wednesday that he sold his position in Tesla stock over the last year.\nThe founder of venture firm Social Capital has been bullish on Tesla (ticker: ...</p>\n\n<a href=\"https://www.barrons.com/articles/tesla-stock-sold-chamath-palihapitiya-51632997123?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.barrons.com/articles/tesla-stock-sold-chamath-palihapitiya-51632997123?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1130437913","content_text":"High-profile investor Chamath Palihapitiya said Wednesday that he sold his position in Tesla stock over the last year.\nThe founder of venture firm Social Capital has been bullish on Tesla (ticker: TSLA) in the past, telling CNBC in January—when the shares were trading hands above $800—that the stock could double or triple in price.\n\nBut the former Facebook executive, and special-purpose acquisition company (SPAC) investor who helped launch Virgin Galactic‘s (SPCE) listing, said he cashed out of Tesla to fund other projects “in the last year or so.”\nSpeaking at a CNBC conference Wednesday, Palihapitiya said he no longer had a sizable stock position in Tesla, having sold down his stake while the stock was on a tear.\n“The price has allowed me to,” Palihapitiya said. “I don’t have an infinite pool of capital.”\n“When I have these ideas, the money has to come from someplace,” the investor said, speaking of a new venture linked to distributed energy utilities.\nTesla stock rose nearly 700% in 2020, from less than $90 a share, to more than $700. It traded near $900 in early 2021, and today hovers around $780, having risen 7% year-to-date, lagging the S&P 500’s 16% and the Dow Jones Industrial Average’s 12%.\nPalihapitiya isn’t the only Tesla booster who has been selling shares of the company. ARK Invest’s Cathie Wood sold more than $200 million of Tesla stock recently. Unlike Palihapitiya, it remains the largest holding in her ARK Innovation ETF (ARKK).","news_type":1},"isVote":1,"tweetType":1,"viewCount":426,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866220463,"gmtCreate":1632786060252,"gmtModify":1632797597286,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/866220463","repostId":"2170622225","repostType":4,"repost":{"id":"2170622225","pubTimestamp":1632766710,"share":"https://www.laohu8.com/m/news/2170622225?lang=&edition=full","pubTime":"2021-09-28 02:18","market":"us","language":"en","title":"Why BioNTech Shares Are Falling","url":"https://stock-news.laohu8.com/highlight/detail?id=2170622225","media":"Benzinga","summary":"Shares of COVID-19 vaccine makers, including BioNTech SE - ADR (NASDAQ: BNTX), are trading lower ami","content":"<p>Shares of COVID-19 vaccine makers, including <b><a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> - ADR</b>&nbsp;(NASDAQ: BNTX),&nbsp;are trading lower amid continued volatility in the space as investors weigh booster shot progress. Pfizer CEO Albert Bourla recently predicted a return to 'normal life' within a year with a likely need for annual shots.</p>\n<p>Shares of companies in growth sectors&nbsp;are also trading lower amid a rise in the 10-year treasury yield.&nbsp;The&nbsp;10-year Treasury yield&nbsp;hit an intraday high of&nbsp;1.517% Monday morning before dipping to around the 1.484% level.&nbsp;The move in the 10-year note&nbsp;comes after the Federal Reserve last week&nbsp;spoke on&nbsp;winding down its ongoing asset purchasing program.</p>\n<p>BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19</p>\n<p>BioNTech has a 52-week high of $464.00 and a 52-week low of $61.27.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why BioNTech Shares Are Falling</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy BioNTech Shares Are Falling\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-28 02:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/why-biontech-shares-falling-181830207.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of COVID-19 vaccine makers, including BioNTech SE - ADR (NASDAQ: BNTX), are trading lower amid continued volatility in the space as investors weigh booster shot progress. Pfizer CEO Albert ...</p>\n\n<a href=\"https://finance.yahoo.com/news/why-biontech-shares-falling-181830207.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE"},"source_url":"https://finance.yahoo.com/news/why-biontech-shares-falling-181830207.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2170622225","content_text":"Shares of COVID-19 vaccine makers, including BioNTech SE - ADR (NASDAQ: BNTX), are trading lower amid continued volatility in the space as investors weigh booster shot progress. Pfizer CEO Albert Bourla recently predicted a return to 'normal life' within a year with a likely need for annual shots.\nShares of companies in growth sectors are also trading lower amid a rise in the 10-year treasury yield. The 10-year Treasury yield hit an intraday high of 1.517% Monday morning before dipping to around the 1.484% level. The move in the 10-year note comes after the Federal Reserve last week spoke on winding down its ongoing asset purchasing program.\nBioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19\nBioNTech has a 52-week high of $464.00 and a 52-week low of $61.27.","news_type":1},"isVote":1,"tweetType":1,"viewCount":263,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866131861,"gmtCreate":1632745362653,"gmtModify":1632798168438,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great[微笑]&nbsp;","listText":"Great[微笑]&nbsp;","text":"Great[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/866131861","repostId":"1104998278","repostType":4,"repost":{"id":"1104998278","pubTimestamp":1632744740,"share":"https://www.laohu8.com/m/news/1104998278?lang=&edition=full","pubTime":"2021-09-27 20:12","market":"sg","language":"en","title":"Binance.com to Restrict Singapore Users From Some Functions","url":"https://stock-news.laohu8.com/highlight/detail?id=1104998278","media":"Bloomberg","summary":"Binance.com is restricting Singapore users’ ability to use its services as it seeks to come into com","content":"<p>Binance.com is restricting Singapore users’ ability to use its services as it seeks to come into compliance with the city-state’s regulations.</p>\n<p>Users in Singapore will not be able to access certain functions on Binance.com as of Oct. 26, including fiat deposit services, spot trading of cryptocurrencies, the purchase of cryptocurrencies through fiat channels and liquid swap, Binance said&nbsp;in a statement&nbsp;on its website.</p>\n<p>The restrictions are being imposed for compliance reasons, it said. Users in Singapore were advised to cease all related trades, withdraw fiat assets and redeem tokens by the October deadline to avoid potential trading disputes.</p>\n<p>Binance, the biggest crypto exchange, has been focused on compliance issues as regulators globally take an increasingly strong interest in the asset class. Previously, Binance said&nbsp;it would halt&nbsp;Singapore products after the central bank&nbsp;warned it might&nbsp;be in breach of local payment rules.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Binance.com to Restrict Singapore Users From Some Functions</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBinance.com to Restrict Singapore Users From Some Functions\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-27 20:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-09-27/binance-com-to-restrict-singapore-users-from-some-functions><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Binance.com is restricting Singapore users’ ability to use its services as it seeks to come into compliance with the city-state’s regulations.\nUsers in Singapore will not be able to access certain ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-09-27/binance-com-to-restrict-singapore-users-from-some-functions\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GBTC":"Grayscale Bitcoin Trust"},"source_url":"https://www.bloomberg.com/news/articles/2021-09-27/binance-com-to-restrict-singapore-users-from-some-functions","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104998278","content_text":"Binance.com is restricting Singapore users’ ability to use its services as it seeks to come into compliance with the city-state’s regulations.\nUsers in Singapore will not be able to access certain functions on Binance.com as of Oct. 26, including fiat deposit services, spot trading of cryptocurrencies, the purchase of cryptocurrencies through fiat channels and liquid swap, Binance said in a statement on its website.\nThe restrictions are being imposed for compliance reasons, it said. Users in Singapore were advised to cease all related trades, withdraw fiat assets and redeem tokens by the October deadline to avoid potential trading disputes.\nBinance, the biggest crypto exchange, has been focused on compliance issues as regulators globally take an increasingly strong interest in the asset class. Previously, Binance said it would halt Singapore products after the central bank warned it might be in breach of local payment rules.","news_type":1},"isVote":1,"tweetType":1,"viewCount":90,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875981671,"gmtCreate":1637594521622,"gmtModify":1637594521622,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875981671","repostId":"2185874833","repostType":2,"repost":{"id":"2185874833","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1637588025,"share":"https://www.laohu8.com/m/news/2185874833?lang=&edition=full","pubTime":"2021-11-22 21:33","market":"us","language":"en","title":"EU says decision on J&J COVID-19 vaccine booster dose 'within weeks'","url":"https://stock-news.laohu8.com/highlight/detail?id=2185874833","media":"Reuters","summary":"Nov 22 (Reuters) - The European Union's drug regulator said on Monday it was evaluating data on boos","content":"<p>Nov 22 (Reuters) - The European Union's drug regulator said on Monday it was evaluating data on booster doses of the COVID-19 vaccine by Johnson &amp; Johnson&nbsp;and a decision could come \"within weeks\" under a speedy review.</p>\n<p>The application is for use of a booster dose of the vaccine, COVID-19 Vaccine Janssen, to be given at least two months after the first dose to people aged 18 years and older, the European Medicines Agency (EMA) said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EU says decision on J&J COVID-19 vaccine booster dose 'within weeks'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEU says decision on J&J COVID-19 vaccine booster dose 'within weeks'\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-11-22 21:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nov 22 (Reuters) - The European Union's drug regulator said on Monday it was evaluating data on booster doses of the COVID-19 vaccine by Johnson &amp; Johnson&nbsp;and a decision could come \"within weeks\" under a speedy review.</p>\n<p>The application is for use of a booster dose of the vaccine, COVID-19 Vaccine Janssen, to be given at least two months after the first dose to people aged 18 years and older, the European Medicines Agency (EMA) said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2185874833","content_text":"Nov 22 (Reuters) - The European Union's drug regulator said on Monday it was evaluating data on booster doses of the COVID-19 vaccine by Johnson & Johnson and a decision could come \"within weeks\" under a speedy review.\nThe application is for use of a booster dose of the vaccine, COVID-19 Vaccine Janssen, to be given at least two months after the first dose to people aged 18 years and older, the European Medicines Agency (EMA) said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":332,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849149290,"gmtCreate":1635737599912,"gmtModify":1635737599968,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Grt","listText":"Grt","text":"Grt","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/849149290","repostId":"1159859530","repostType":4,"isVote":1,"tweetType":1,"viewCount":699,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":826694096,"gmtCreate":1634010123981,"gmtModify":1634010123981,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Good info","listText":"Good info","text":"Good info","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/826694096","repostId":"2174186083","repostType":4,"isVote":1,"tweetType":1,"viewCount":588,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":867219986,"gmtCreate":1633270125073,"gmtModify":1633270125185,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Yes offcourse&nbsp;","listText":"Yes offcourse&nbsp;","text":"Yes offcourse","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/867219986","repostId":"2172962172","repostType":4,"repost":{"id":"2172962172","pubTimestamp":1633190400,"share":"https://www.laohu8.com/m/news/2172962172?lang=&edition=full","pubTime":"2021-10-03 00:00","market":"us","language":"en","title":"Can Amplitude Compete With Big Tech","url":"https://stock-news.laohu8.com/highlight/detail?id=2172962172","media":"Motley Fool","summary":"Here's how Amplitude stacks up against Adobe and Google.","content":"<span> <p>Digital optimization specialist <strong>Amplitude </strong><span>(NASDAQ:AMPL)</span> became the latest cloud stock to make a splash in the public markets, landing on the <strong>Nasdaq&nbsp;</strong>Tuesday through a direct listing.</p> <p>The software company enters the stock market with strong momentum with revenue up 57% in the first half of the year to reach $129 million in the last four quarters. It's also going public at a time when interest in cloud stocks has soared as the so-called \"digital transformation\" has accelerated business demand for cloud software. However, Amplitude is up against some stiff competition in analytics, including entrenched players like <strong><a href=\"https://laohu8.com/S/ADBE\">Adobe</a>&nbsp;</strong>and Google, which offer their own packages under Adobe <a href=\"https://laohu8.com/S/EXP.AU\">Experience</a> Cloud and Google Analytics. Let's take a look at how plans to differentiate itself as it carves out a new niche in digital optimization.</p> \n <div>\n  <img src=\"https://static.tigerbbs.com/e9d500e7e3bddcf91e4e0edd2c0867fa\" srcset=\"https://g.foolcdn.com/image/?url=https%3A//g.foolcdn.com/editorial/images/644876/amplitude-ipo-2.jpg&amp;w=300&amp;op=resize 300w, https://g.foolcdn.com/image/?url=https%3A//g.foolcdn.com/editorial/images/644876/amplitude-ipo-2.jpg&amp;w=1000&amp;op=resize 1000w, https://g.foolcdn.com/image/?url=https%3A//g.foolcdn.com/editorial/images/644876/amplitude-ipo-2.jpg&amp;w=2000&amp;op=resize 2000w\"> \n  <p>Image source: Amplitude.</p> \n </div> <h2>Marketing vs. product</h2> <p>Some investors sizing up Amplitude believe that the company faces a crowded field, competing with the likes of Google Analytics, which is widely adopted and has a popular free tier. However, there are some important differences between Amplitude and its big tech competitors. In the S-1, the company argues, \"Businesses have used a range of point solutions built for other use cases in an effort to address their needs, but none of which offer the breadth and depth of capabilities offered by our Digital Optimization System.\"</p> <p>According to Amplitude CEO Spenser Skates, what distinguishes his company is its focus on providing step-by-step data on the performance of a digital product rather than analytics for marketing, which is what Adobe and Google focus on. Amplitude sells to the Chief Product Officer while offerings from competitors appeal to the Chief Marketing Officer.</p>\n <div></div> <p>In an interview with the Motley Fool, Skates explained, \"The biggest thing that we come up against is Adobe and Google Analytics. It's kind of the previous generation of marketing-centric tools that were built for the CMO (Chief Marketing Officer). Product teams are forced to use them and they get frustrated and that's when they end up coming to us.\" Skates added, \"The question for us isn't competition. It's how big is this trend going to be,\" meaning running a product team through data. </p> <p>That focus on product is finding a wide audience as Amplitude now has 1,280 customers, including 26% of the Fortune 100 and 22 with annual recurring revenue above $1 million, as well as 311 with ARR above $100,000. The company has also expanded from selling to tech companies like <strong><a href=\"https://laohu8.com/S/TWTR\">Twitter</a> </strong>and <strong>Atlassian </strong>to selling to mainstream consumer-facing companies like <strong>Walmart</strong>,&nbsp;<strong>Ford</strong>, Burger King, and NBC as those companies have realized the importance of tracking the performance of their digital products.</p> <p>For example, Amplitude helped&nbsp;<strong>Anheuser-Busch&nbsp;</strong>transition its sales model to a digital-first <a href=\"https://laohu8.com/S/AONE.U\">one</a>, and the company's retail customers now receive daily personalized recommendations based on AI to stock the right assortments. </p> <h2>The opportunity ahead</h2> <p>Skates sees the opportunity in front of his company largely as a greenfield one, or an untapped, emerging market. The company estimates its total addressable market to be valued at $37 billion, which is based on a bottom-up estimate extrapolating data from its current customer base to the broader market.&nbsp;</p>\n <div></div> <p>It will take the market time to evolve as the company generated less than 1% of that value in revenue in the last four quarters, but the pandemic has accelerated the \"digital transformation,\" or the process of every company building tech infrastructure. As Skates sees it, digital optimization is the next step in that evolution. Once companies like Anheuser-Busch have the tech infrastructure in place, they are going to look for ways to use it to improve their business.</p> <p>While competition is a risk for almost any company and the competitive field is evolving in digital optimization, the threat from Google or Adobe doesn't seem to be significant enough to avoid the stock. For now, the most important challenge for Amplitude is executing on its business and making the sale to Chief Product Officers.</p> \n <div></div> </span>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Can Amplitude Compete With Big Tech</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCan Amplitude Compete With Big Tech\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-03 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/03/can-amplitude-compete-with-big-tech/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Digital optimization specialist Amplitude (NASDAQ:AMPL) became the latest cloud stock to make a splash in the public markets, landing on the Nasdaq Tuesday through a direct listing. The software ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/03/can-amplitude-compete-with-big-tech/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMPL":"AmplitudeE, Inc."},"source_url":"https://www.fool.com/investing/2021/10/03/can-amplitude-compete-with-big-tech/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2172962172","content_text":"Digital optimization specialist Amplitude (NASDAQ:AMPL) became the latest cloud stock to make a splash in the public markets, landing on the Nasdaq Tuesday through a direct listing. The software company enters the stock market with strong momentum with revenue up 57% in the first half of the year to reach $129 million in the last four quarters. It's also going public at a time when interest in cloud stocks has soared as the so-called \"digital transformation\" has accelerated business demand for cloud software. However, Amplitude is up against some stiff competition in analytics, including entrenched players like Adobe and Google, which offer their own packages under Adobe Experience Cloud and Google Analytics. Let's take a look at how plans to differentiate itself as it carves out a new niche in digital optimization.\n\n\nImage source: Amplitude.\n Marketing vs. product Some investors sizing up Amplitude believe that the company faces a crowded field, competing with the likes of Google Analytics, which is widely adopted and has a popular free tier. However, there are some important differences between Amplitude and its big tech competitors. In the S-1, the company argues, \"Businesses have used a range of point solutions built for other use cases in an effort to address their needs, but none of which offer the breadth and depth of capabilities offered by our Digital Optimization System.\" According to Amplitude CEO Spenser Skates, what distinguishes his company is its focus on providing step-by-step data on the performance of a digital product rather than analytics for marketing, which is what Adobe and Google focus on. Amplitude sells to the Chief Product Officer while offerings from competitors appeal to the Chief Marketing Officer.\n In an interview with the Motley Fool, Skates explained, \"The biggest thing that we come up against is Adobe and Google Analytics. It's kind of the previous generation of marketing-centric tools that were built for the CMO (Chief Marketing Officer). Product teams are forced to use them and they get frustrated and that's when they end up coming to us.\" Skates added, \"The question for us isn't competition. It's how big is this trend going to be,\" meaning running a product team through data.  That focus on product is finding a wide audience as Amplitude now has 1,280 customers, including 26% of the Fortune 100 and 22 with annual recurring revenue above $1 million, as well as 311 with ARR above $100,000. The company has also expanded from selling to tech companies like Twitter and Atlassian to selling to mainstream consumer-facing companies like Walmart, Ford, Burger King, and NBC as those companies have realized the importance of tracking the performance of their digital products. For example, Amplitude helped Anheuser-Busch transition its sales model to a digital-first one, and the company's retail customers now receive daily personalized recommendations based on AI to stock the right assortments.  The opportunity ahead Skates sees the opportunity in front of his company largely as a greenfield one, or an untapped, emerging market. The company estimates its total addressable market to be valued at $37 billion, which is based on a bottom-up estimate extrapolating data from its current customer base to the broader market. \n It will take the market time to evolve as the company generated less than 1% of that value in revenue in the last four quarters, but the pandemic has accelerated the \"digital transformation,\" or the process of every company building tech infrastructure. As Skates sees it, digital optimization is the next step in that evolution. Once companies like Anheuser-Busch have the tech infrastructure in place, they are going to look for ways to use it to improve their business. While competition is a risk for almost any company and the competitive field is evolving in digital optimization, the threat from Google or Adobe doesn't seem to be significant enough to avoid the stock. For now, the most important challenge for Amplitude is executing on its business and making the sale to Chief Product Officers.","news_type":1},"isVote":1,"tweetType":1,"viewCount":298,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865400406,"gmtCreate":1633008440042,"gmtModify":1633008440180,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865400406","repostId":"2171937752","repostType":4,"repost":{"id":"2171937752","pubTimestamp":1633002256,"share":"https://www.laohu8.com/m/news/2171937752?lang=&edition=full","pubTime":"2021-09-30 19:44","market":"us","language":"en","title":"4 Stocks Expected to Increase Sales 25,750% to 2,970,000% in 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2171937752","media":"Motley Fool","summary":"These companies could deliver jaw-dropping revenue growth through mid-decade.","content":"<p>High-growth stocks have dominated Wall Street for more than a decade -- and with good reason. Historically low lending rates and an accommodative monetary policy have paved the way for fast-paced companies to borrow at attractive rates.</p>\n<p>But for some companies, sales growth is about to kick into high gear. When you're building a business from the ground up, going from practically nothing in sales to hundreds of millions or billions of dollars in revenue in just a couple of years can be a jaw-dropping experience.</p>\n<p>The following four companies are expected to do just that. According to Wall Street's consensus estimates, these four stocks are forecast to increase sales by 25,750% to as much as 2,970,000% (that's nearly 3 million percent) over the next five years.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ee55796575e48ba3143c099af095e386\" tg-width=\"700\" tg-height=\"535\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Vaxart: 25,752% implied sales growth by 2025</h2>\n<p>A clinical-stage biotech stock angling for its first approved therapy is a perfect example of a business that could grow from a relatively small amount of non-recurring revenue to a considerably larger sum of recurring sales. Drug-developer <b>Vaxart</b> (NASDAQ:VXRT) is expected to increase its annual sales from the $4.05 million reported in 2020 to a consensus estimate of $1.047 billion by mid-decade. That's an increase of about 25,750%, if Wall Street's numbers prove accurate.</p>\n<p>Vaxart's future is pinned to the success of its VAAST platform. \"VAAST\" stands for Vector-Adjuvant-Antigen Standardized Technology and encompasses the company's attempts to develop proprietary oral vaccines. Whereas standard vaccines administered in a shot can activate systemic immunity, oral-vaccine tablets would be designed to activate systemic and mucosal immunity in the intestines, lungs, nose, and mouth. In other words, this dual-action approach could carry better immunity against potentially deadly viruses.</p>\n<p>The oral vaccine that's arguably received the most attention for Vaxart is VXA-CoV2-1, an early-stage tablet designed to combat the coronavirus disease 2019 (COVID-19). In May, Vaxart announced that its phase 1 study of VXA-CoV2-1 led to clear immune response in participants, although high levels of neutralizing antibodies weren't present. Traditional shot-in-the-arm vaccines have led to high levels of neutralizing antibodies in clinical trials.</p>\n<p>But Vaxart's work isn't close to being finished. In early August, it received the go-ahead from the U.S. Food and Drug Administration (FDA) to commence an oral-tablet study for a very specific protein to combat COVID-19. It could be some time before investors know if oral vaccines are a viable solution, but the convenience factor certainly makes this trial worth watching.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/650d01a926fded89c361069c76a528f5\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>CRISPR Technologies: 191,416% implied sales growth by 2025</h2>\n<p>Did I mention that clinical-stage biotech stocks are a great source of jaw-dropping growth over the next decade? <b>CRISPR Therapeutics</b> (NASDAQ:CRSP), a company leaning on gene-editing technology to precisely alter genomic DNA and tackle hard-to-treat diseases, is expected to see sales climb from $719,000 in 2020 to a consensus of $1.377 billion by 2025. That's an improvement of more than 191,000% in five years.</p>\n<p>Arguably the biggest positive for CRISPR is that it's working with <b>Vertex Pharmaceuticals</b> (NASDAQ:VRTX) in the development of CTX001 for the treatment of transfusion-dependent beta thalassemia (TDT) and sickle cell disease (SCD). Vertex has a storied history of developing novel therapies for hard-to-treat illnesses, such as cystic fibrosis.</p>\n<p>It also doesn't hurt that Vertex's deep pockets are helping to lift CRISPR's bank account. Following a $900 million collaboration payment in the second quarter, CRISPR was sitting on nearly $2.6 billion in cash, cash equivalents, and marketable securities. That's plenty of capital to fund its ongoing clinical studies.</p>\n<p>Initial trial data for CTX001 has also been encouraging. At the European Hematology Association's annual meeting in June, the company announced that all 15 patients with TDT were transfusion-free after follow-ups of at least three months. TDT patients can require weekly transfusions, depending on the severity of their illnesses. Management believes regulatory filings, assuming all goes well in clinical studies, could come by or before mid-2023.</p>\n<p>While CRISPR Technologies is far from the only company looking to tackle TDT and SCD, it's among the best funded and has Vertex in its corner. That gives it a better-than-average chance of success, at least in my book.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a38605bee8e62f3e8aa414fa24278e7e\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Ocugen: 604,551% implied sales growth by 2025</h2>\n<p>Yet another clinical-stage biotech company expected to see sales go from virtually zero to a big number with a lot of zeroes is <b>Ocugen</b> (NASDAQ:OCGN). After the company reported $43,000 in sales last year, Wall Street's consensus has it generating $260 million in full-year sales by 2025. We're talking about a nearly 605,000% sales increase in five years.</p>\n<p>Not to sound like a broken record, but a COVID-19 vaccine is Ocugen's potential catalyst. The company has partnered with India's Bharat Biotech for the commercialization of Covaxin. A phase 3 trial of 25,800 adults aged 18 and up in India demonstrated a vaccine efficacy of 77.8% for symptomatic infections, 63.6% against asymptomatic infections, and most importantly was 93.4% effective against severe COVID-19 disease. The July-reported data from Bharat also showed a 65.2% efficacy against the delta variant.</p>\n<p>With so many people left to be vaccinated, this probably sounds like a slam-dunk for some form of emergency authorization use in developed or emerging markets. However, there's a big problem for Ocugen: It only has co-commercialization rights for Covaxin in the U.S. and Canada. The U.S. has ordered more-than-enough vaccines to inoculate all eligible Americans, and likely has doses in reserve should booster shots become necessary. The same could be said for Canada, which invested heavily in vaccine purchases.</p>\n<p>While there's no such thing as having too many vaccine options during a pandemic, Covaxin's initial efficacy doesn't pop quite like the vaccines from <b>Moderna</b>, <b>Pfizer</b>/<b>BioNTech</b>, or even <b>Novavax</b>, which looks to be nearing its own emergency use authorization in the United States. Suffice it to say, Ocugen's sales forecast may prove unattainable.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/deae33b8912cffd8d0ba896164abff66\" tg-width=\"700\" tg-height=\"378\" width=\"100%\" height=\"auto\"><span>A rendering of the all-electric Nikola Tre semi. Image source: Nikola.</span></p>\n<h2>Nikola: 2,970,426% implied sales growth by 2025</h2>\n<p>However, the crème de la crème of growth opportunities, at least pertaining to this list, is electric vehicle (EV) manufacturer <b>Nikola</b> (NASDAQ:NKLA). The expectation is that we'll see Nikola's sales catapult from a reported $95,000 in 2020 to a consensus of $2.822 billion by 2025. This equates to almost a 3 million percent jump in annual revenue.</p>\n<p>The growth opportunity for EVs is pretty straightforward. With developed countries like the U.S. tackling climate change head-on, replacing fossil-fuel-burning vehicles with alternative-energy vehicles is <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the easiest ways to make a difference. It's going to take decades for consumers and businesses to make this shift, which leaves plenty of room for multiple EV manufacturers to thrive.</p>\n<p>The issue for Nikola is that it's dealing with a public relations mess. Last year, short-side firm Hindenburg Research released a report that alleged Nikola was a fraud. Even though an independent review found that many of Hindenburg's allegations weren't true, it was discovered that founder Trevor Milton's statements regarding pre-sells weren't accurate.</p>\n<p>Despite stepping down last year, Milton was indicted by the U.S. Department of Justice on three charges of misleading investors. Ultimately, Nikola will have to overcome a breach of trust to sell its vehicles, and it likely will need a lot more cash than it has now to build up its production. Personally, I'm skeptical the company will reach this lofty sales consensus by mid-decade.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Stocks Expected to Increase Sales 25,750% to 2,970,000% in 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Stocks Expected to Increase Sales 25,750% to 2,970,000% in 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-30 19:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/30/4-stocks-increase-sales-25750-to-2970000-5-years/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>High-growth stocks have dominated Wall Street for more than a decade -- and with good reason. Historically low lending rates and an accommodative monetary policy have paved the way for fast-paced ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/30/4-stocks-increase-sales-25750-to-2970000-5-years/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NKLA":"Nikola Corporation","VXRT":"Vaxart, Inc","OCGN":"Ocugen","CRSP":"CRISPR Therapeutics AG"},"source_url":"https://www.fool.com/investing/2021/09/30/4-stocks-increase-sales-25750-to-2970000-5-years/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2171937752","content_text":"High-growth stocks have dominated Wall Street for more than a decade -- and with good reason. Historically low lending rates and an accommodative monetary policy have paved the way for fast-paced companies to borrow at attractive rates.\nBut for some companies, sales growth is about to kick into high gear. When you're building a business from the ground up, going from practically nothing in sales to hundreds of millions or billions of dollars in revenue in just a couple of years can be a jaw-dropping experience.\nThe following four companies are expected to do just that. According to Wall Street's consensus estimates, these four stocks are forecast to increase sales by 25,750% to as much as 2,970,000% (that's nearly 3 million percent) over the next five years.\nImage source: Getty Images.\nVaxart: 25,752% implied sales growth by 2025\nA clinical-stage biotech stock angling for its first approved therapy is a perfect example of a business that could grow from a relatively small amount of non-recurring revenue to a considerably larger sum of recurring sales. Drug-developer Vaxart (NASDAQ:VXRT) is expected to increase its annual sales from the $4.05 million reported in 2020 to a consensus estimate of $1.047 billion by mid-decade. That's an increase of about 25,750%, if Wall Street's numbers prove accurate.\nVaxart's future is pinned to the success of its VAAST platform. \"VAAST\" stands for Vector-Adjuvant-Antigen Standardized Technology and encompasses the company's attempts to develop proprietary oral vaccines. Whereas standard vaccines administered in a shot can activate systemic immunity, oral-vaccine tablets would be designed to activate systemic and mucosal immunity in the intestines, lungs, nose, and mouth. In other words, this dual-action approach could carry better immunity against potentially deadly viruses.\nThe oral vaccine that's arguably received the most attention for Vaxart is VXA-CoV2-1, an early-stage tablet designed to combat the coronavirus disease 2019 (COVID-19). In May, Vaxart announced that its phase 1 study of VXA-CoV2-1 led to clear immune response in participants, although high levels of neutralizing antibodies weren't present. Traditional shot-in-the-arm vaccines have led to high levels of neutralizing antibodies in clinical trials.\nBut Vaxart's work isn't close to being finished. In early August, it received the go-ahead from the U.S. Food and Drug Administration (FDA) to commence an oral-tablet study for a very specific protein to combat COVID-19. It could be some time before investors know if oral vaccines are a viable solution, but the convenience factor certainly makes this trial worth watching.\nImage source: Getty Images.\nCRISPR Technologies: 191,416% implied sales growth by 2025\nDid I mention that clinical-stage biotech stocks are a great source of jaw-dropping growth over the next decade? CRISPR Therapeutics (NASDAQ:CRSP), a company leaning on gene-editing technology to precisely alter genomic DNA and tackle hard-to-treat diseases, is expected to see sales climb from $719,000 in 2020 to a consensus of $1.377 billion by 2025. That's an improvement of more than 191,000% in five years.\nArguably the biggest positive for CRISPR is that it's working with Vertex Pharmaceuticals (NASDAQ:VRTX) in the development of CTX001 for the treatment of transfusion-dependent beta thalassemia (TDT) and sickle cell disease (SCD). Vertex has a storied history of developing novel therapies for hard-to-treat illnesses, such as cystic fibrosis.\nIt also doesn't hurt that Vertex's deep pockets are helping to lift CRISPR's bank account. Following a $900 million collaboration payment in the second quarter, CRISPR was sitting on nearly $2.6 billion in cash, cash equivalents, and marketable securities. That's plenty of capital to fund its ongoing clinical studies.\nInitial trial data for CTX001 has also been encouraging. At the European Hematology Association's annual meeting in June, the company announced that all 15 patients with TDT were transfusion-free after follow-ups of at least three months. TDT patients can require weekly transfusions, depending on the severity of their illnesses. Management believes regulatory filings, assuming all goes well in clinical studies, could come by or before mid-2023.\nWhile CRISPR Technologies is far from the only company looking to tackle TDT and SCD, it's among the best funded and has Vertex in its corner. That gives it a better-than-average chance of success, at least in my book.\nImage source: Getty Images.\nOcugen: 604,551% implied sales growth by 2025\nYet another clinical-stage biotech company expected to see sales go from virtually zero to a big number with a lot of zeroes is Ocugen (NASDAQ:OCGN). After the company reported $43,000 in sales last year, Wall Street's consensus has it generating $260 million in full-year sales by 2025. We're talking about a nearly 605,000% sales increase in five years.\nNot to sound like a broken record, but a COVID-19 vaccine is Ocugen's potential catalyst. The company has partnered with India's Bharat Biotech for the commercialization of Covaxin. A phase 3 trial of 25,800 adults aged 18 and up in India demonstrated a vaccine efficacy of 77.8% for symptomatic infections, 63.6% against asymptomatic infections, and most importantly was 93.4% effective against severe COVID-19 disease. The July-reported data from Bharat also showed a 65.2% efficacy against the delta variant.\nWith so many people left to be vaccinated, this probably sounds like a slam-dunk for some form of emergency authorization use in developed or emerging markets. However, there's a big problem for Ocugen: It only has co-commercialization rights for Covaxin in the U.S. and Canada. The U.S. has ordered more-than-enough vaccines to inoculate all eligible Americans, and likely has doses in reserve should booster shots become necessary. The same could be said for Canada, which invested heavily in vaccine purchases.\nWhile there's no such thing as having too many vaccine options during a pandemic, Covaxin's initial efficacy doesn't pop quite like the vaccines from Moderna, Pfizer/BioNTech, or even Novavax, which looks to be nearing its own emergency use authorization in the United States. Suffice it to say, Ocugen's sales forecast may prove unattainable.\nA rendering of the all-electric Nikola Tre semi. Image source: Nikola.\nNikola: 2,970,426% implied sales growth by 2025\nHowever, the crème de la crème of growth opportunities, at least pertaining to this list, is electric vehicle (EV) manufacturer Nikola (NASDAQ:NKLA). The expectation is that we'll see Nikola's sales catapult from a reported $95,000 in 2020 to a consensus of $2.822 billion by 2025. This equates to almost a 3 million percent jump in annual revenue.\nThe growth opportunity for EVs is pretty straightforward. With developed countries like the U.S. tackling climate change head-on, replacing fossil-fuel-burning vehicles with alternative-energy vehicles is one of the easiest ways to make a difference. It's going to take decades for consumers and businesses to make this shift, which leaves plenty of room for multiple EV manufacturers to thrive.\nThe issue for Nikola is that it's dealing with a public relations mess. Last year, short-side firm Hindenburg Research released a report that alleged Nikola was a fraud. Even though an independent review found that many of Hindenburg's allegations weren't true, it was discovered that founder Trevor Milton's statements regarding pre-sells weren't accurate.\nDespite stepping down last year, Milton was indicted by the U.S. Department of Justice on three charges of misleading investors. Ultimately, Nikola will have to overcome a breach of trust to sell its vehicles, and it likely will need a lot more cash than it has now to build up its production. Personally, I'm skeptical the company will reach this lofty sales consensus by mid-decade.","news_type":1},"isVote":1,"tweetType":1,"viewCount":267,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866223170,"gmtCreate":1632786117990,"gmtModify":1632797597025,"author":{"id":"4092798624667290","authorId":"4092798624667290","name":"brijeshnair","avatar":"https://static.tigerbbs.com/7fd087acb258af07a4837fa64d38c77a","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/866223170","repostId":"2170995644","repostType":4,"repost":{"id":"2170995644","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1632756343,"share":"https://www.laohu8.com/m/news/2170995644?lang=&edition=full","pubTime":"2021-09-27 23:25","market":"us","language":"en","title":"Amazon to start offering insurance to UK businesses -broker","url":"https://stock-news.laohu8.com/highlight/detail?id=2170995644","media":"Reuters","summary":"LONDON, Sept 27 (Reuters) - Amazon.com Inc is to start offering insurance to small and medium-sized ","content":"<p>LONDON, Sept 27 (Reuters) - Amazon.com Inc is to start offering insurance to small and medium-sized UK business customers, the technology giant's first foray into business insurance in the country, broker&nbsp;Superscript said on Monday.</p>\n<p>Members of Amazon's Business Prime programme will be able to buy cover from Superscript such as contents insurance, cyber insurance and personal indemnity insurance</p>\n<p>which a Superscript spokesperson said would be underwritten by \"major UK insurers\". They will be offered a discount of 20% to current rates as a way of enticing businesses over to them.</p>\n<p>More than 50% of customers are prepared to buy insurance from non-traditional players such as big tech or insurance technology (insurtech) firms, according to a recent survey of 12,000 people globally by consultants Capgemini.</p>\n<p>\"The (insurance) industry needs to bridge the divide between insurers and customers by providing a quick, smooth buying process that is customer-centric,\" Cameron Shearer, co-founder and CEO of Superscript, said in a statement.</p>\n<p>Amazon's move into UK business insurance comes after U.S. insurtech Next Insurance said in March it was offering cover to U.S. small businesses via Amazon Business Prime.</p>\n<p>\"As businesses come out of the pandemic and gradually resume normalcy, we want customers to have the best-in-class tools to run their business,\" Molly Dobson, Country Manager for Amazon Business UK &amp; Ireland, said in the statement.</p>\n<p>Financial institutions are worried that tech firms will steal their business, trading on the tech players' stronger brand names and ease of access to their products.</p>\n<p>But industry sources said insurers or banks and tech firms are more likely to forge partnerships than compete directly, given the difficulties and expense for outsiders in entering the highly regulated finance sector.</p>\n<p>Amazon also offers warranty insurance and \"buy now, pay later\" services in Britain.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amazon to start offering insurance to UK businesses -broker</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmazon to start offering insurance to UK businesses -broker\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-27 23:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LONDON, Sept 27 (Reuters) - Amazon.com Inc is to start offering insurance to small and medium-sized UK business customers, the technology giant's first foray into business insurance in the country, broker&nbsp;Superscript said on Monday.</p>\n<p>Members of Amazon's Business Prime programme will be able to buy cover from Superscript such as contents insurance, cyber insurance and personal indemnity insurance</p>\n<p>which a Superscript spokesperson said would be underwritten by \"major UK insurers\". They will be offered a discount of 20% to current rates as a way of enticing businesses over to them.</p>\n<p>More than 50% of customers are prepared to buy insurance from non-traditional players such as big tech or insurance technology (insurtech) firms, according to a recent survey of 12,000 people globally by consultants Capgemini.</p>\n<p>\"The (insurance) industry needs to bridge the divide between insurers and customers by providing a quick, smooth buying process that is customer-centric,\" Cameron Shearer, co-founder and CEO of Superscript, said in a statement.</p>\n<p>Amazon's move into UK business insurance comes after U.S. insurtech Next Insurance said in March it was offering cover to U.S. small businesses via Amazon Business Prime.</p>\n<p>\"As businesses come out of the pandemic and gradually resume normalcy, we want customers to have the best-in-class tools to run their business,\" Molly Dobson, Country Manager for Amazon Business UK &amp; Ireland, said in the statement.</p>\n<p>Financial institutions are worried that tech firms will steal their business, trading on the tech players' stronger brand names and ease of access to their products.</p>\n<p>But industry sources said insurers or banks and tech firms are more likely to forge partnerships than compete directly, given the difficulties and expense for outsiders in entering the highly regulated finance sector.</p>\n<p>Amazon also offers warranty insurance and \"buy now, pay later\" services in Britain.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2170995644","content_text":"LONDON, Sept 27 (Reuters) - Amazon.com Inc is to start offering insurance to small and medium-sized UK business customers, the technology giant's first foray into business insurance in the country, broker Superscript said on Monday.\nMembers of Amazon's Business Prime programme will be able to buy cover from Superscript such as contents insurance, cyber insurance and personal indemnity insurance\nwhich a Superscript spokesperson said would be underwritten by \"major UK insurers\". They will be offered a discount of 20% to current rates as a way of enticing businesses over to them.\nMore than 50% of customers are prepared to buy insurance from non-traditional players such as big tech or insurance technology (insurtech) firms, according to a recent survey of 12,000 people globally by consultants Capgemini.\n\"The (insurance) industry needs to bridge the divide between insurers and customers by providing a quick, smooth buying process that is customer-centric,\" Cameron Shearer, co-founder and CEO of Superscript, said in a statement.\nAmazon's move into UK business insurance comes after U.S. insurtech Next Insurance said in March it was offering cover to U.S. small businesses via Amazon Business Prime.\n\"As businesses come out of the pandemic and gradually resume normalcy, we want customers to have the best-in-class tools to run their business,\" Molly Dobson, Country Manager for Amazon Business UK & Ireland, said in the statement.\nFinancial institutions are worried that tech firms will steal their business, trading on the tech players' stronger brand names and ease of access to their products.\nBut industry sources said insurers or banks and tech firms are more likely to forge partnerships than compete directly, given the difficulties and expense for outsiders in entering the highly regulated finance sector.\nAmazon also offers warranty insurance and \"buy now, pay later\" services in Britain.","news_type":1},"isVote":1,"tweetType":1,"viewCount":262,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}